BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis. 2008;197:1016-1027. [PMID: 18419539 DOI: 10.1086/528996] [Cited by in Crossref: 382] [Cited by in F6Publishing: 365] [Article Influence: 27.3] [Reference Citation Analysis]
Number Citing Articles
1 Marès Bermúdez J, van Esso Arbolave D, Moreno-pérez D, Merino Moína M, Álvarez García F, Cilleruelo Ortega M, Arístegui Fernández J, Ortigosa del Castillo L, Ruiz-contreras J, Barrio Corrales F, González-hachero J. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2011. Anales de Pediatría 2011;74:132.e1-132.e19. [DOI: 10.1016/j.anpedi.2010.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
2 Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, Lu M, So TM, Hsueh PR, Yasin RM, Carlos CC, Pham HV, Lalitha MK, Shimono N, Perera J, Shibl AM, Baek JY, Kang CI, Ko KS, Peck KR; ANSORP Study Group. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012;56:1418-26. [PMID: 22232285 DOI: 10.1128/AAC.05658-11] [Cited by in Crossref: 221] [Cited by in F6Publishing: 101] [Article Influence: 22.1] [Reference Citation Analysis]
3 Klugman KP, Rodgers GL. Time for a third-generation pneumococcal conjugate vaccine. Lancet Infect Dis 2021;21:14-6. [PMID: 32702301 DOI: 10.1016/S1473-3099(20)30513-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Mott M, Caierão J, Rosa da Cunha G, Rodrigues Perez LR, Matusiak R, Pilger de Oliveira KR, d’Azevedo PA, Dias C. Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil. International Journal of Infectious Diseases 2014;20:47-51. [DOI: 10.1016/j.ijid.2013.11.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
5 Holmlund E, Nohynek H, Quiambao B, Ollgren J, Käyhty H. Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination. Vaccine 2011;29:4565-75. [PMID: 21550374 DOI: 10.1016/j.vaccine.2011.04.068] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
6 Demczuk WHB, Martin I, Desai S, Griffith A, Caron-Poulin L, Lefebvre B, McGeer A, Tyrrell GJ, Zhanel GG, Gubbay J, Hoang L, Levett PN, Van Caeseele P, Raafat Gad R, Haldane D, Zahariadis G, German G, Daley Bernier J, Strudwick L, Mulvey MR. Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016. Vaccine 2018;36:4701-7. [PMID: 29937245 DOI: 10.1016/j.vaccine.2018.06.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Picazo JJ, Ruiz-Contreras J, Casado-Flores J, Negreira S, Baquero-Artigao F, Hernández-Sampelayo T, Otheo E, Amo MD, Méndez C; Heracles Study Group. Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study. Vaccine 2019;37:2200-7. [PMID: 30902478 DOI: 10.1016/j.vaccine.2019.03.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Lee M, Chen C, Chuang T, Huang Y, Hsueh P. Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009–2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance. International Journal of Antimicrobial Agents 2013;42:395-402. [DOI: 10.1016/j.ijantimicag.2013.07.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
9 McGee L, Biek D, Ge Y, Klugman M, du Plessis M, Smith AM, Beall B, Whitney CG, Klugman KP. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2009;53:552-6. [PMID: 19015339 DOI: 10.1128/AAC.01324-08] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
10 Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, McGee L, von Gottberg A, Song JH, Ko KS, Pichon B, Baker S, Parry CM, Lambertsen LM, Shahinas D, Pillai DR, Mitchell TJ, Dougan G, Tomasz A, Klugman KP, Parkhill J, Hanage WP, Bentley SD. Rapid pneumococcal evolution in response to clinical interventions. Science 2011;331:430-4. [PMID: 21273480 DOI: 10.1126/science.1198545] [Cited by in Crossref: 663] [Cited by in F6Publishing: 599] [Article Influence: 60.3] [Reference Citation Analysis]
11 Pillai DR, Shahinas D, Buzina A, Pollock RA, Lau R, Khairnar K, Wong A, Farrell DJ, Green K, McGeer A, Low DE. Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009;10:642. [PMID: 20042094 DOI: 10.1186/1471-2164-10-642] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 6.2] [Reference Citation Analysis]
12 Chappuy H, Keitel K, Gehri M, Tabin R, Robitaille L, Raymond F, Corbeil J, Maspoli V, Bouazza N, Alcoba G, Lacroix L, Manzano S, Galetto-Lacour A, Gervaix A. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland. BMC Infect Dis 2013;13:357. [PMID: 23899390 DOI: 10.1186/1471-2334-13-357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
13 Williams SR, Mernagh PJ, Lee MHT, Tan JT. Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7‐valent pneumococcal conjugate vaccine. Medical Journal of Australia 2011;194:116-20. [DOI: 10.5694/j.1326-5377.2011.tb04192.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
14 Nelson JC, Jackson M, Yu O, Whitney CG, Bounds L, Bittner R, Zavitkovsky A, Jackson LA. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 2008;26:4947-54. [PMID: 18662735 DOI: 10.1016/j.vaccine.2008.07.016] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 7.2] [Reference Citation Analysis]
15 Deng X, Church D, Vanderkooi OG, Low DE, Pillai DR. Streptococcus pneumoniae infection: a Canadian perspective. Expert Review of Anti-infective Therapy 2014;11:781-91. [DOI: 10.1586/14787210.2013.814831] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
16 Kim KS. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 2008;6:625-34. [PMID: 18604221 DOI: 10.1038/nrmicro1952] [Cited by in Crossref: 264] [Cited by in F6Publishing: 234] [Article Influence: 18.9] [Reference Citation Analysis]
17 Kim L, McGee L, Tomczyk S, Beall B. Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective. Clin Microbiol Rev 2016;29:525-52. [PMID: 27076637 DOI: 10.1128/CMR.00058-15] [Cited by in Crossref: 136] [Cited by in F6Publishing: 69] [Article Influence: 22.7] [Reference Citation Analysis]
18 Marès Bermúdez J, van Esso Arbolave D, Arístegui Fernández J, Ruiz Contreras J, González Hachero J, Merino Moína M, Barrio Corrales F, Álvarez García F, Cilleruelo Ortega M, Ortigosa del Castillo L, Moreno Pérez D. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2010. Anales de Pediatría 2010;72:433.e1-433.e17. [DOI: 10.1016/j.anpedi.2010.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
19 Donkor ES, Bishop CJ, Gould K, Hinds J, Antonio M, Wren B, Hanage WP. High levels of recombination among Streptococcus pneumoniae isolates from the Gambia. mBio 2011;2:e00040-11. [PMID: 21693638 DOI: 10.1128/mBio.00040-11] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
20 Somech I, Dagan R, Givon-Lavi N, Porat N, Raiz S, Leiberman A, Puterman M, Peled N, Greenberg D, Leibovitz E. Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine. Vaccine 2011;29:4202-9. [PMID: 21497634 DOI: 10.1016/j.vaccine.2011.03.103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
21 Golden AR, Rosenthal M, Fultz B, Nichol KA, Adam HJ, Gilmour MW, Baxter MR, Hoban DJ, Karlowsky JA, Zhanel GG. Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13. J Antimicrob Chemother 2015;70:2199-202. [PMID: 25921512 DOI: 10.1093/jac/dkv107] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
22 Olarte L, Jackson MA. Streptococcus pneumoniae. Pediatr Rev 2021;42:349-59. [PMID: 34210754 DOI: 10.1542/pir.2020-0062] [Reference Citation Analysis]
23 Muñoz-almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. Journal of Infection 2011;63:151-62. [DOI: 10.1016/j.jinf.2011.06.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
24 Ubukata K, Takata M, Morozumi M, Chiba N, Wajima T, Hanada S, Shouji M, Sakuma M, Iwata S; Invasive Pneumococcal Diseases Surveillance Study Group. Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017. Emerg Infect Dis 2018;24:2010-20. [PMID: 30334707 DOI: 10.3201/eid2411.180326] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 19.0] [Reference Citation Analysis]
25 Esposito S, Tansey S, Thompson A, Razmpour A, Liang J, Jones TR, Ferrera G, Maida A, Bona G, Sabatini C, Pugni L, Emini EA, Gruber WC, Scott DA, Principi N. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers. Clin Vaccine Immunol 2010;17:1017-26. [PMID: 20427630 DOI: 10.1128/CVI.00062-10] [Cited by in Crossref: 114] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
26 Cornick J, Bentley S. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides. Microbes and Infection 2012;14:573-83. [DOI: 10.1016/j.micinf.2012.01.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
27 Massire C, Gertz RE Jr, Svoboda P, Levert K, Reed MS, Pohl J, Kreft R, Li F, White N, Ranken R, Blyn LB, Ecker DJ, Sampath R, Beall B. Concurrent serotyping and genotyping of pneumococci by use of PCR and electrospray ionization mass spectrometry. J Clin Microbiol 2012;50:2018-25. [PMID: 22442313 DOI: 10.1128/JCM.06735-11] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
28 Isturiz R, Sings HL, Hilton B, Arguedas A, Reinert R, Jodar L. Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert Review of Vaccines 2017;16:1007-27. [DOI: 10.1080/14760584.2017.1362339] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 12.6] [Reference Citation Analysis]
29 Rodgers GL, Klugman KP. The future of pneumococcal disease prevention. Vaccine 2011;29 Suppl 3:C43-8. [PMID: 21896352 DOI: 10.1016/j.vaccine.2011.07.047] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
30 Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. The Lancet Infectious Diseases 2011;11:760-8. [DOI: 10.1016/s1473-3099(11)70090-1] [Cited by in Crossref: 475] [Cited by in F6Publishing: 199] [Article Influence: 43.2] [Reference Citation Analysis]
31 Frenck R, Thompson A, Yeh SH, London A, Sidhu MS, Patterson S, Gruber WC, Emini EA, Scott DA, Gurtman A. Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine. Pediatric Infectious Disease Journal 2011;30:1086-91. [DOI: 10.1097/inf.0b013e3182372c6a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
32 Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M. Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines. Journal of Infectious Diseases 2012;205:401-11. [DOI: 10.1093/infdis/jir755] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 7.3] [Reference Citation Analysis]
33 Dagan R. Serotype replacement in perspective. Vaccine 2009;27 Suppl 3:C22-4. [PMID: 19545935 DOI: 10.1016/j.vaccine.2009.06.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
34 Liñares J, Ardanuy C, Pallares R, Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clinical Microbiology and Infection 2010;16:402-10. [DOI: 10.1111/j.1469-0691.2010.03182.x] [Cited by in Crossref: 187] [Cited by in F6Publishing: 180] [Article Influence: 15.6] [Reference Citation Analysis]
35 Samai P, Pyenson N, Jiang W, Goldberg GW, Hatoum-Aslan A, Marraffini LA. Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity. Cell 2015;161:1164-74. [PMID: 25959775 DOI: 10.1016/j.cell.2015.04.027] [Cited by in Crossref: 240] [Cited by in F6Publishing: 207] [Article Influence: 34.3] [Reference Citation Analysis]
36 Weil Olivier C. Ten years of experience with the pneumococcal conjugate 7-valent vaccine in children. Médecine et Maladies Infectieuses 2013;43:309-21. [DOI: 10.1016/j.medmal.2013.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
37 Golubchik T, Brueggemann AB, Street T, Gertz RE Jr, Spencer CC, Ho T, Giannoulatou E, Link-Gelles R, Harding RM, Beall B, Peto TE, Moore MR, Donnelly P, Crook DW, Bowden R. Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet 2012;44:352-5. [PMID: 22286217 DOI: 10.1038/ng.1072] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 7.6] [Reference Citation Analysis]
38 Lamaro-Cardoso J, de Lemos APS, Carvalho MDG, Pimenta FC, Roundtree A, Motta L, Vieira MA, Sgambatti S, Thörn LK, Pessoa-Junior V, Minamisava R, Harrison LH, Beall BW, Brandileone MCC, Andrade AL. Molecular epidemiological investigation to determine the source of a fatal case of serotype 22F pneumococcal meningitis. J Med Microbiol 2012;61:686-92. [PMID: 22286925 DOI: 10.1099/jmm.0.040790-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Mitchell PK, Lipsitch M, Hanage WP. Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci. Philos Trans R Soc Lond B Biol Sci 2015;370:20140342. [PMID: 25918447 DOI: 10.1098/rstb.2014.0342] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
40 Schranz J. Pneumococcal conjugate vaccines: what do we know and what do we need? Procedia in Vaccinology 2009;1:189-205. [DOI: 10.1016/j.provac.2009.07.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
41 Straume D, Stamsås GA, Håvarstein LS. Natural transformation and genome evolution in Streptococcus pneumoniae. Infect Genet Evol 2015;33:371-80. [PMID: 25445643 DOI: 10.1016/j.meegid.2014.10.020] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
42 Ahn JG, Choi SY, Kim DS, Kim KH. Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines. Infect Dis (Lond) 2015;47:385-92. [PMID: 25712791 DOI: 10.3109/00365548.2014.1001997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
43 Zhang B, Gertz RE, Liu Z, Li Z, Fu W, Beall B. Characterization of highly antimicrobial-resistant clinical pneumococcal isolates recovered in a Chinese hospital during 2009-2010. J Med Microbiol 2012;61:42-8. [PMID: 21873379 DOI: 10.1099/jmm.0.035675-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
44 Reinert R, Jacobs MR, Kaplan SL. Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development. Vaccine 2010;28:4249-59. [DOI: 10.1016/j.vaccine.2010.04.020] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 8.7] [Reference Citation Analysis]
45 Spijkerman J, van Gils EJ, Veenhoven RH, Hak E, Yzerman F, van der Ende A, Wijmenga-monsuur AJ, van den Dobbelsteen GP, Sanders EA. Carriage of Streptococcus pneumoniae 3 Years after Start of Vaccination Program, the Netherlands. Emerg Infect Dis 2011;17:584-91. [DOI: 10.3201/eid1704.101115] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 7.0] [Reference Citation Analysis]
46 Scott JR, Hanage WP, Lipsitch M, Millar EV, Moulton LH, Hinds J, Reid R, Santosham M, O’brien KL. Pneumococcal sequence type replacement among American Indian children: A comparison of pre- and routine-PCV7 eras. Vaccine 2012;30:2376-81. [DOI: 10.1016/j.vaccine.2011.11.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
47 Nguyen HAT, Fujii H, Vu HTT, Parry CM, Dang AD, Ariyoshi K, Yoshida LM. An alarmingly high nasal carriage rate of Streptococcus pneumoniae serotype 19F non-susceptible to multiple beta-lactam antimicrobials among Vietnamese children. BMC Infect Dis 2019;19:241. [PMID: 30866853 DOI: 10.1186/s12879-019-3861-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
48 Link-Gelles R, Thomas A, Lynfield R, Petit S, Schaffner W, Harrison L, Farley MM, Aragon D, Nicols M, Kirley PD, Zansky S, Jorgensen J, Juni BA, Jackson D, Moore MR, Lipsitch M. Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States. J Infect Dis 2013;208:1266-73. [PMID: 23852588 DOI: 10.1093/infdis/jit315] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
49 Klugman KP, Black S, Dagan R, Malley R, Whitney CG. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines. Elsevier; 2013. pp. 504-41. [DOI: 10.1016/b978-1-4557-0090-5.00032-x] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
50 Shivshankar P, Sanchez C, Rose LF, Orihuela CJ. The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells. Mol Microbiol 2009;73:663-79. [PMID: 19627498 DOI: 10.1111/j.1365-2958.2009.06796.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 8.2] [Reference Citation Analysis]
51 Cho EY, Lee H, Choi EH, Kim YJ, Eun BW, Cho YK, Kim YK, Jo DS, Lee HS, Lee J, Kim MN, Kim DS, Lee HJ. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010. Diagn Microbiol Infect Dis 2014;78:481-6. [PMID: 24529940 DOI: 10.1016/j.diagmicrobio.2013.12.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
52 Ubukata K, Morozumi M, Sakuma M, Takata M, Mokuno E, Tajima T, Iwata S; AOM Surveillance Study Group. Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates After Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children. Pediatr Infect Dis J 2018;37:598-604. [PMID: 29474258 DOI: 10.1097/INF.0000000000001956] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
53 Jackson LA, Janoff EN. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin Infect Dis 2008;47:1328-38. [PMID: 18844484 DOI: 10.1086/592691] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 6.5] [Reference Citation Analysis]
54 Singleton R, Wenger J, Klejka JA, Bulkow LR, Thompson A, Sarkozy D, Emini EA, Gruber WC, Scott DA. The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial. Pediatr Infect Dis J 2013;32:257-63. [PMID: 23001026 DOI: 10.1097/INF.0b013e3182748ada] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
55 Ip M, Chau SS, Lai LS, Ma H, Chan PK, Nelson EA. Increased nasopharyngeal carriage of serotypes 6A, 6C, and 6D Streptococcus pneumoniae after introduction of childhood pneumococcal vaccination in Hong Kong. Diagn Microbiol Infect Dis 2013;76:153-7. [PMID: 23541419 DOI: 10.1016/j.diagmicrobio.2013.02.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
56 Pace D. Glycoconjugate vaccines. Expert Opinion on Biological Therapy 2012;13:11-33. [DOI: 10.1517/14712598.2012.725718] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
57 Chiappini E, Galli L, Bonsignori F, Venturini E, Principi N, de Martino M. Self-reported pediatricians' management of the well-appearing young child with fever without a source: first survey in an European country in the anti-pneumococcal vaccine era. BMC Public Health 2009;9:300. [PMID: 19689826 DOI: 10.1186/1471-2458-9-300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
58 Salter SJ, Hinds J, Gould KA, Lambertsen L, Hanage WP, Antonio M, Turner P, Hermans PWM, Bootsma HJ, O'Brien KL, Bentley SD. Variation at the capsule locus, cps, of mistyped and non-typable Streptococcus pneumoniae isolates. Microbiology (Reading) 2012;158:1560-9. [PMID: 22403189 DOI: 10.1099/mic.0.056580-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
59 Hjálmarsdóttir MÁ, Haraldsson G, Quirk SJ, Haraldsson Á, Erlendsdóttir H, Kristinsson KG. Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland. PLoS One 2020;15:e0230332. [PMID: 32182260 DOI: 10.1371/journal.pone.0230332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Doit C, Mariani-Kurkdjian P, Mahjoub-Messai F, Bidet P, Bonacorsi S, Carol A, Varon E, Bingen E. Epidemiology of pediatric community-acquired bloodstream infections in a children hospital in Paris, France, 2001 to 2008. Diagn Microbiol Infect Dis 2010;66:332-5. [PMID: 20159378 DOI: 10.1016/j.diagmicrobio.2009.10.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
61 Chen YY, Wang JT, Lin TL, Gong YN, Li TH, Huang YY, Hsieh YC. Prophage Excision in Streptococcus pneumoniae Serotype 19A ST320 Promote Colonization: Insight Into Its Evolution From the Ancestral Clone Taiwan 19F-14 (ST236). Front Microbiol 2019;10:205. [PMID: 30800118 DOI: 10.3389/fmicb.2019.00205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
62 Nakamura MM, Tasslimi A, Lieu TA, Levine O, Knoll MD, Russell LB, Sinha A. Cost effectiveness of child pneumococcal conjugate vaccination in middle-income countries. International Health 2011;3:270-81. [DOI: 10.1016/j.inhe.2011.08.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
63 Hausdorff W, Dagan R, Beckers F, Schuerman L. Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease. Vaccine 2009;27:7257-69. [DOI: 10.1016/j.vaccine.2009.09.111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
64 Strutton DR, Farkouh RA, Earnshaw SR, Hwang S, Theidel U, Kontodimas S, Klok R, Papanicolaou S. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands. J Infect 2012;64:54-67. [PMID: 22085813 DOI: 10.1016/j.jinf.2011.10.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
65 Fenoll A, Aguilar L, Giménez MJ, Vicioso MD, Robledo O, Granizo JJ, Coronel P. Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine. Antimicrob Agents Chemother. 2010;54:2696-2698. [PMID: 20308373 DOI: 10.1128/aac.01594-09] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
66 Spijkerman J, van Gils EJ, Veenhoven RH, Hak E, Yzerman EP, van der Ende A, Wijmenga-Monsuur AJ, van den Dobbelsteen GP, Sanders EA. Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis 2011;17:584-91. [PMID: 21470445 DOI: 10.3201/eid1704.101115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
67 Pittet LF, Posfay-Barbe KM. Pneumococcal vaccines for children: a global public health priority. Clin Microbiol Infect 2012;18 Suppl 5:25-36. [PMID: 22862432 DOI: 10.1111/j.1469-0691.2012.03938.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
68 Banerjee R, Hersh AL, Newland J, Beekmann SE, Polgreen PM, Bender J, Shaw J, Copelovitch L, Kaplan BS, Shah SS. Streptococcus pneumoniae-associated Hemolytic Uremic Syndrome Among Children in North America. Pediatric Infectious Disease Journal 2011;30:736-9. [DOI: 10.1097/inf.0b013e3182191c58] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
69 Beall B, Chochua S, Gertz RE Jr, Li Y, Li Z, McGee L, Metcalf BJ, Ricaldi J, Tran T, Walker H, Pilishvili T. A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015-2016. Front Microbiol 2018;9:2670. [PMID: 30524382 DOI: 10.3389/fmicb.2018.02670] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
70 Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. The Lancet Infectious Diseases 2008;8:785-95. [DOI: 10.1016/s1473-3099(08)70281-0] [Cited by in Crossref: 174] [Cited by in F6Publishing: 63] [Article Influence: 12.4] [Reference Citation Analysis]
71 Mahjoub-Messai F, Doit C, Mariani-Kurkdjian P, François M, Bingen E. [Epidemiology of acute otitis media caused by Streptococcus pneumoniae: emergence of serotype 19A]. Arch Pediatr 2008;15:1713-6. [PMID: 18926673 DOI: 10.1016/j.arcped.2008.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
72 Croucher NJ, Chewapreecha C, Hanage WP, Harris SR, McGee L, van der Linden M, Song JH, Ko KS, de Lencastre H, Turner C, Yang F, Sá-Leão R, Beall B, Klugman KP, Parkhill J, Turner P, Bentley SD. Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape. Genome Biol Evol 2014;6:1589-602. [PMID: 24916661 DOI: 10.1093/gbe/evu120] [Cited by in Crossref: 76] [Cited by in F6Publishing: 60] [Article Influence: 9.5] [Reference Citation Analysis]
73 Mehta S. Developing the right pneumococcal vaccine for the time and place. Am J Trop Med Hyg 2010;83:449-50. [PMID: 20810802 DOI: 10.4269/ajtmh.2010.10-0313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
74 Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, Beall B, Satola S, Jerris R, Jain S, Farley MM, Nuorti JP. Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine: Comparison With the Era Before 7-valent Conjugate Vaccine. Pediatric Infectious Disease Journal 2013;32:e45-53. [DOI: 10.1097/inf.0b013e3182788fdd] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
75 Porat N, Amit U, Givon-lavi N, Leibovitz E, Dagan R. Increasing Importance of Multidrug-Resistant Serotype 6A Streptococcus pneumoniae Clones in Acute Otitis Media in Southern Israel. Pediatric Infectious Disease Journal 2010;29:126-30. [DOI: 10.1097/inf.0b013e3181b78e6e] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
76 Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect 2011;17 Suppl 6:E1-59. [PMID: 21951385 DOI: 10.1111/j.1469-0691.2011.03672.x] [Cited by in Crossref: 442] [Cited by in F6Publishing: 405] [Article Influence: 44.2] [Reference Citation Analysis]
77 Casado-Flores J, Rodrigo C, Arístegui J, Martínón JM, Fenoll A, Mendez C. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1020-1022. [PMID: 18845983 DOI: 10.1097/inf.0b013e31817bd2dc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
78 Makarewicz O, Lucas M, Brandt C, Herrmann L, Albersmeier A, Rückert C, Blom J, Goesmann A, van der Linden M, Kalinowski J, Pletz MW. Whole Genome Sequencing of 39 Invasive Streptococcus pneumoniae Sequence Type 199 Isolates Revealed Switches from Serotype 19A to 15B. PLoS One 2017;12:e0169370. [PMID: 28046133 DOI: 10.1371/journal.pone.0169370] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
79 Rose M, Zielen S. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe. Expert Review of Vaccines 2014;8:1351-64. [DOI: 10.1586/erv.09.78] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
80 Nair H, Watts AT, Williams LJ, Omer SB, Simpson CR, Willocks LJ, Cameron JC, Campbell H. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children. BMC Infect Dis 2016;16:390. [PMID: 27506837 DOI: 10.1186/s12879-016-1693-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
81 Gonzales BE, Mercado EH, Pinedo-bardales M, Hinostroza N, Campos F, Chaparro E, Del Águila O, Castillo ME, Saenz A, Reyes I, Ochoa TJ. Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru. Front Cell Infect Microbiol 2022;12:866186. [DOI: 10.3389/fcimb.2022.866186] [Reference Citation Analysis]
82 Abu Seir R, Azmi K, Hamdan A, Namouz H, Jaar F, Jaber H, Rubin C, Doron D, Rahav G, Abdeen Z, Regev-Yochay G. Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR). PLoS One 2018;13:e0206927. [PMID: 30418989 DOI: 10.1371/journal.pone.0206927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
83 Ndlangisa KM, du Plessis M, Wolter N, de Gouveia L, Klugman KP, von Gottberg A; GERMS-SA. Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines. PLoS One 2014;9:e107666. [PMID: 25233455 DOI: 10.1371/journal.pone.0107666] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
84 Principi N, Esposito S. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease. Expert Rev Vaccines 2015;14:1359-66. [PMID: 26289973 DOI: 10.1586/14760584.2015.1075884] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
85 Tyrrell GJ, Lovgren M, Chui N, Minion J, Garg S, Kellner JD, Marrie TJ. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006. Vaccine. 2009;27:3553-3560. [PMID: 19464534 DOI: 10.1016/j.vaccine.2009.03.063] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
86 Baek JY, Ko KS, Kim SH, Kang C, Chung DR, Peck KR, Song J. Comparison of genotypes of Streptococcus pneumoniae serotypes 6A and 6B before and after the introduction of PCV7 vaccination in Korea. Diagnostic Microbiology and Infectious Disease 2011;69:370-5. [DOI: 10.1016/j.diagmicrobio.2010.10.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
87 Keenan JD, Klugman KP, McGee L, Vidal JE, Chochua S, Hawkins P, Cevallos V, Gebre T, Tadesse Z, Emerson PM, Jorgensen JH, Gaynor BD, Lietman TM. Evidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments. J Infect Dis 2015;211:988-94. [PMID: 25293366 DOI: 10.1093/infdis/jiu552] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
88 Guevara S, Abdelnour A, Soley C, Porat N, Dagan R, Arguedas A. Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population. Vaccine 2012;30:3857-61. [PMID: 22521846 DOI: 10.1016/j.vaccine.2012.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
89 Payne AB, Link-Gelles R, Azonobi I, Hooper WC, Beall BW, Jorgensen JH, Juni B, Moore M; Active Bacterial Core Surveillance Team. Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009. Pediatr Infect Dis J 2013;32:1308-12. [PMID: 23811745 DOI: 10.1097/INF.0b013e3182a11808] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
90 Schroeder MR, Lohsen S, Chancey ST, Stephens DS. High-Level Macrolide Resistance Due to the Mega Element [mef(E)/mel] in Streptococcus pneumoniae. Front Microbiol 2019;10:868. [PMID: 31105666 DOI: 10.3389/fmicb.2019.00868] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
91 Hulten KG, Kaplan SL, Lamberth LB, Barson WJ, Romero JR, Lin PL, Bradley JS, Givner LB, Tan TQ, Hoffman JA, Mason EO. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol 2013;51:1294-7. [PMID: 23390277 DOI: 10.1128/JCM.00058-13] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
92 Yildirim M, Keskinocak P, Pelton S, Pickering L, Yildirim I. Who is at risk of 13-valent conjugated pneumococcal vaccine failure? Vaccine 2020;38:1671-7. [DOI: 10.1016/j.vaccine.2019.12.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
93 Matsuyama T, Fukuda Y, Sakai T, Tanimoto N, Nakanishi M, Nakamura Y, Takano T, Nakayasu C. Clonal structure in Ichthyobacterium seriolicida , the causative agent of bacterial haemolytic jaundice in yellowtail, Seriola quinqueradiata , inferred from molecular epidemiological analysis. J Fish Dis 2017;40:1065-75. [DOI: 10.1111/jfd.12586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
94 Rudolph K, Bruce M, Bruden D, Zulz T, Wenger J, Reasonover A, Harker-Jones M, Hurlburt D, Hennessy T. Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009. Diagn Microbiol Infect Dis 2013;75:271-6. [PMID: 23276772 DOI: 10.1016/j.diagmicrobio.2012.11.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
95 Arguedas A, Abdelnour A, Soley C, Jimenez E, Jimenez AL, Ramcharran D, Porat N, Dagan R, Gray S, Rodgers GL. Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica. Vaccine 2012;30:2342-8. [DOI: 10.1016/j.vaccine.2012.01.047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
96 Madhi SA. Pneumococcal conjugate vaccine and changing epidemiology of childhood bacterial meningitis. J Pediatr (Rio J) 2015;91:108-10. [PMID: 25475554 DOI: 10.1016/j.jped.2014.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
97 Dortet L, Ploy M, Poyart C, Raymond J. Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology. Diagnostic Microbiology and Infectious Disease 2009;65:49-57. [DOI: 10.1016/j.diagmicrobio.2009.05.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
98 Dinleyici EC, Yargic ZA. 27th Annual Meeting of the European Society for Pediatric Infectious Disease. Expert Review of Vaccines 2014;8:1143-9. [DOI: 10.1586/erv.09.75] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
99 de Waure C, Specchia ML, Capizzi S, Aljicevic M, Dujovic M, Malaj A, Ricciardi W. Effectiveness of 7-valent pneumococcal conjugate vaccine: A meta-analysis of post-marketing studies. World J Meta-Anal 2015; 3(3): 151-162 [DOI: 10.13105/wjma.v3.i3.151] [Reference Citation Analysis]
100 Zhao C, Xie Y, Zhang F, Wang Z, Yang S, Wang Q, Wang X, Li H, Chen H, Wang H. Investigation of Antibiotic Resistance, Serotype Distribution, and Genetic Characteristics of 164 Invasive Streptococcus pneumoniae from North China Between April 2016 and October 2017. Infect Drug Resist 2020;13:2117-28. [PMID: 32753907 DOI: 10.2147/IDR.S256663] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
101 Castañeda E, Agudelo CI, De Antonio R, Rosselli D, Calderón C, Ortega-Barria E, Colindres RE. Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010. BMC Infect Dis 2012;12:124. [PMID: 22639955 DOI: 10.1186/1471-2334-12-124] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
102 Desai S, McGeer A, Quach-Thanh C, Elliott D; approved by NACI. Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2010;36:1-21. [PMID: 31697280 DOI: 10.14745/ccdr.v36i00a12] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
103 Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjöström K, Morfeldt E, Naucler P, Blennow M, Örtqvist Å, Henriques-Normark B. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur Respir J 2016;47:1208-18. [PMID: 26797033 DOI: 10.1183/13993003.01451-2015] [Cited by in Crossref: 97] [Cited by in F6Publishing: 84] [Article Influence: 16.2] [Reference Citation Analysis]
104 Mitchell PK, Azarian T, Croucher NJ, Callendrello A, Thompson CM, Pelton SI, Lipsitch M, Hanage WP. Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13. Microb Genom 2019;5. [PMID: 30777813 DOI: 10.1099/mgen.0.000252] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
105 Ubukata K, Chiba N, Hanada S, Morozumi M, Wajima T, Shouji M, Iwata S; Invasive Pneumococcal Diseases Surveillance Study Group. Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010-2013. Emerg Infect Dis 2015;21:1956-65. [PMID: 26485679 DOI: 10.3201/eid2111.142029] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
106 Adebanjo TA, Pondo T, Yankey D, Hill HA, Gierke R, Apostol M, Barnes M, Petit S, Farley M, Harrison LH, Holtzman C, Baumbach J, Bennett N, McGuire S, Thomas A, Schaffner W, Beall B, Whitney CG, Pilishvili T. Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016. Pediatrics 2020;145:e20190836. [PMID: 32054822 DOI: 10.1542/peds.2019-0836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
107 Chochua S, Metcalf BJ, Li Z, Walker H, Tran T, McGee L, Beall B. Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage, United States, 2015-2016. Emerg Infect Dis 2017;23:922-30. [PMID: 28516866 DOI: 10.3201/eid2306.170071] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
108 Salleras L, Domínguez A, Ciruela P, Izquierdo C, Navas E, Torner N, Borras E. Changes in serotypes causing invasive pneumococcal disease (2005–2007 vs. 1997–1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine. Clinical Microbiology and Infection 2009;15:997-1001. [DOI: 10.1111/j.1469-0691.2009.02938.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
109 Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clinical Microbiology and Infection 2009;15:16-20. [DOI: 10.1111/j.1469-0691.2009.02726.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 7.1] [Reference Citation Analysis]
110 Harrison LH. Vaccines for Prevention of Group B Meningococcal Disease: Not Your Father's Vaccines. Am J Prev Med 2015;49:S345-54. [PMID: 26590434 DOI: 10.1016/j.amepre.2015.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
111 Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009;302:758-66. [PMID: 19690308 DOI: 10.1001/jama.2009.1163] [Cited by in Crossref: 348] [Cited by in F6Publishing: 316] [Article Influence: 26.8] [Reference Citation Analysis]
112 Schuerman L, Wysocki J, Tejedor JC, Knuf M, Kim KH, Poolman J. Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption. Clin Vaccine Immunol 2011;18:2161-7. [PMID: 21994351 DOI: 10.1128/CVI.05313-11] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
113 Friedel V, Zilora S, Bogaard D, Casey JR, Pichichero ME. Five-year prospective study of paediatric acute otitis media in Rochester, NY: modelling analysis of the risk of pneumococcal colonization in the nasopharynx and infection. Epidemiol Infect 2014;142:2186-94. [PMID: 24480055 DOI: 10.1017/S0950268813003178] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
114 Shoji H, Maeda M, Takuma T, Niki Y. Serotype distribution of Streptococcus pneumoniae isolated from adult respiratory tract infections in nationwide Japanese surveillances from 2006 to 2014. J Infect Chemother 2017;23:538-44. [PMID: 28623109 DOI: 10.1016/j.jiac.2017.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
115 Hurmic O, Grall N, Al Nakib M, Poyart C, Grondin S, Ploy M, Varon E, Raymond J; The ORP Ile de France-Ouest Network. Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system. Eur J Clin Microbiol Infect Dis 2014;33:2067-73. [DOI: 10.1007/s10096-014-2148-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
116 Denis O, Rodriguez-villalobos H, Struelens MJ. The problem of resistance. Antibiotic and Chemotherapy. Elsevier; 2010. pp. 24-48. [DOI: 10.1016/b978-0-7020-4064-1.00003-8] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
117 Akata K, Chang B, Yatera K, Kawanami T, Naito K, Noguchi S, Kido T, Mukae H. The distribution and annual changes in the Streptococcus pneumoniae serotypes in adult Japanese patients with pneumococcal pneumonia from 2011 to 2015. J Infect Chemother 2017;23:301-6. [PMID: 28262532 DOI: 10.1016/j.jiac.2017.01.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
118 Barlow RS, Reynolds LE, Cieslak PR, Sullivan AD. Vaccinated Children and Adolescents With Pertussis Infections Experience Reduced Illness Severity and Duration, Oregon, 2010–2012. Clinical Infectious Diseases 2014;58:1523-9. [DOI: 10.1093/cid/ciu156] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
119 Bautista-Márquez A, Richardson V, Ortiz-Orozco O, Luna-Cruz ME, Carnalla-Barajas MN, Echaniz-Avilés G, Bobadilla-del Valle M, Martínez-Medina L, Montalvo-Vázquez AM, de la Re-Montaño N, Anchondo-Martínez I, Tinoco-Favila JC, Martínez-Aguilar G, Yberri-Zárate I, Girón-Hernández JA, Sifuentes-Osornio J, Guerrero ML, Ruiz-Palacios GM. Prevalence of pneumococcal disease, serotype distribution, and antimicrobial susceptibility in Mexican children younger than 5 years of age. Arch Med Res 2013;44:142-50. [PMID: 23291380 DOI: 10.1016/j.arcmed.2012.12.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
120 Camacho Moreno G, Imbachi LF, Leal AL, Moreno VM, Patiño JA, Gutiérrez IF, Beltrán S, Álvarez-Olmos MI, Mariño C, Barrero R, Espinosa F, Ramos N, Castellar LP, Sánchez N, Montañez A. Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10. Hum Vaccin Immunother 2020;16:2300-6. [PMID: 32078398 DOI: 10.1080/21645515.2019.1710411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
121 Dobay O, Amyes SG, Nagy K. The effect of the 7-valent conjugate vaccine (PCV7) on the incidence of pneumococcal infections world-wide. Reviews in Medical Microbiology 2008;19:79-85. [DOI: 10.1097/mrm.0b013e3283299fa8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
122 Chi H, Chiu NC, Huang FY, Hsu CH, Lee KS, Huang LM, Hsieh YC. Acute otitis media caused by Streptococcus pneumoniae serotype 19A ST320 clone: epidemiological and clinical characteristics. J Microbiol Immunol Infect 2018;51:337-43. [PMID: 28087317 DOI: 10.1016/j.jmii.2016.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
123 Rodríguez-Avial I, Ramos B, Ríos E, Cercenado E, Ordobás M, Sanz JC; Madrid Streptococcus pneumoniae Microbiological Group. Clonal spread of levofloxacin-resistant streptococcus pneumoniae invasive isolates in Madrid, Spain, 2007 to 2009. Antimicrob Agents Chemother 2011;55:2469-71. [PMID: 21383091 DOI: 10.1128/AAC.01380-10] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
124 Reinert RR, Paradiso P, Fritzell B. Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe. Expert Rev Vaccines 2010;9:229-36. [PMID: 20218848 DOI: 10.1586/erv.10.6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
125 Tanaka J, Ishiwada N, Wada A, Chang B, Hishiki H, Kurosaki T, Kohno Y. Incidence of childhood pneumonia and serotype and sequence-type distribution in Streptococcus pneumoniae isolates in Japan. Epidemiol Infect 2012;140:1111-21. [PMID: 21875450 DOI: 10.1017/S0950268811001592] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
126 Soneji S, Metlay J. Mortality reductions for older adults differ by race/ethnicity and gender since the introduction of adult and pediatric pneumococcal vaccines. Public Health Rep 2011;126:259-69. [PMID: 21387956 DOI: 10.1177/003335491112600217] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
127 du Plessis M, Allam M, Tempia S, Wolter N, de Gouveia L, von Mollendorf C, Jolley KA, Mbelle N, Wadula J, Cornick JE, Everett DB, McGee L, Breiman RF, Gladstone RA, Bentley SD, Klugman KP, von Gottberg A. Phylogenetic Analysis of Invasive Serotype 1 Pneumococcus in South Africa, 1989 to 2013. J Clin Microbiol 2016;54:1326-34. [PMID: 26962082 DOI: 10.1128/JCM.00055-16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
128 Moran GJ, Rothman RE, Volturo GA. Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines. Am J Emerg Med 2013;31:602-12. [PMID: 23380120 DOI: 10.1016/j.ajem.2012.12.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
129 Jacobs DM, Yung F, Hart E, Nguyen MN, Shaver A. Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States. Vaccine 2017;35:6160-5. [DOI: 10.1016/j.vaccine.2017.09.050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
130 Mitsi E, McLenaghan D, Wolf AS, Jones S, Collins AM, Hyder-Wright A, Goldblatt D, Heyderman RS, Gordon SB, Ferreira DM. PCV13 induced IgG responses in serum associate with serotype-specific IgG in the lung. J Infect Dis 2021:jiab331. [PMID: 34159375 DOI: 10.1093/infdis/jiab331] [Reference Citation Analysis]
131 Otsuka T, Chang B, Wada A, Okazaki M. Molecular epidemiology and serogroup 6 capsular gene evolution of pneumococcal carriage in a Japanese birth cohort study. Journal of Medical Microbiology 2013;62:1868-75. [DOI: 10.1099/jmm.0.066316-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
132 Hanage WP, Bishop CJ, Huang SS, Stevenson AE, Pelton SI, Lipsitch M, Finkelstein JA. Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J 2011;30:302-8. [PMID: 21085049 DOI: 10.1097/INF.0b013e318201a154] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
133 Zhuo F, Xiao M, Kong F, Oftadeh S, Zhou F, Zhang J, Gilbert GL. Prevalence and genetic diversity of pneumococcal serogroup 6 in Australia. Clin Microbiol Infect 2011;17:1246-53. [PMID: 20950338 DOI: 10.1111/j.1469-0691.2010.03404.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
134 Rockett RJ, Oftadeh S, Bachmann NL, Timms VJ, Kong F, Gilbert GL, Sintchenko V. Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia. Sci Rep 2018;8:16969. [PMID: 30446692 DOI: 10.1038/s41598-018-35270-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
135 Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis 2011;203:1360-8. [PMID: 21398395 DOI: 10.1093/infdis/jir052] [Cited by in Crossref: 126] [Cited by in F6Publishing: 116] [Article Influence: 11.5] [Reference Citation Analysis]
136 Alexandrova A, Pencheva D, Mitov I, Setchanova L. Phenotypic and genotypic characteristics of non-invasive S. pneumoniae isolates recovered from PCV10-vaccinated children in Bulgaria. Indian J Med Microbiol 2021:S0255-0857(21)04654-5. [PMID: 34772534 DOI: 10.1016/j.ijmmb.2021.10.004] [Reference Citation Analysis]
137 Park DC, Kim SH, Yong D, Suh IB, Kim YR, Yi J, Song W, Song SA, Moon HW, Lee HK, Park KU, Kim S, Jeong SH, Lee J, Jeong J, Kim YK, Lee M, Cho J, Kim JW, Shin KS, Hwang SH, Chung JW, Woo HI, Lee CH, Ryoo N, Chang CL, Kim HS, Kim J, Shin JH, Kim SH, Lee MK, Lee SG, Jang SJ, Lee K, Suh H, Sohn YH, Kwon MJ, Lee HJ, Hong KH, Woo KS, Park CM, Shin JH. Serotype Distribution and Antimicrobial Resistance of Invasive and Noninvasive Streptococcus pneumoniae Isolates in Korea between 2014 and 2016. Ann Lab Med 2019;39:537-44. [PMID: 31240881 DOI: 10.3343/alm.2019.39.6.537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
138 Laitinen S, Vaara M, Salo E. Pneumococcal serotype distribution in invasive paediatric disease in Southern Finland before the introduction of vaccine. Scand J Infect Dis. 2010;42:924-930. [PMID: 20735331 DOI: 10.3109/00365548.2010.510532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
139 Tali-maamar H, Laliam R, Bentchouala C, Touati D, Sababou K, Azrou S, Azzam M, Amhis W, Oussadou L, Belouni R, Smati F, Rahal K. Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010. Médecine et Maladies Infectieuses 2012;42:59-65. [DOI: 10.1016/j.medmal.2011.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
140 González Martínez F, Saavedra Lozano J, Navarro Gómez ML, Santos Sebastián MM, Rodríguez Fernández R, González Sánchez M, Hernández-Sampelayo Matos T. [Increase in the incidence of invasive pneumococcal disease caused by serotype 19A prior to the implementation of the expanded pneumococcal vaccines]. An Pediatr (Barc) 2013;79:288-92. [PMID: 23587534 DOI: 10.1016/j.anpedi.2013.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
141 Cohen R, Levy C, Bonnet E, Thollot F, Boucherat M, Fritzell B, Derkx V, Bingen E, Varon E. Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination. BMC Infect Dis 2011;11:95. [PMID: 21501471 DOI: 10.1186/1471-2334-11-95] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
142 Gherardi G, D'Ambrosio F, Visaggio D, Dicuonzo G, Del Grosso M, Pantosti A. Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine era in Italy. Antimicrob Agents Chemother 2012;56:4965-8. [PMID: 22751537 DOI: 10.1128/AAC.00830-12] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
143 Wroe PC, Lee GM, Finkelstein JA, Pelton SI, Hanage WP, Lipsitch M, Stevenson AE, Rifas-Shiman SL, Kleinman K, Dutta-Linn MM. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J. 2012;31:249-254. [PMID: 22173142 DOI: 10.1097/inf.0b013e31824214ac] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
144 Dockrell DH, Whyte MKB, Mitchell TJ. Pneumococcal pneumonia: mechanisms of infection and resolution. Chest 2012;142:482-91. [PMID: 22871758 DOI: 10.1378/chest.12-0210] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
145 Cohen R, Levy C, Bingen E, Koskas M, Nave I, Varon E. Impact of 13-valent Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Carriage in Children With Acute Otitis Media. Pediatric Infectious Disease Journal 2012;31:297-301. [DOI: 10.1097/inf.0b013e318247ef84] [Cited by in Crossref: 133] [Cited by in F6Publishing: 47] [Article Influence: 13.3] [Reference Citation Analysis]
146 Brugger SD, Frey P, Aebi S, Hinds J, Mühlemann K. Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine. PLoS One 2010;5:e11638. [PMID: 20661289 DOI: 10.1371/journal.pone.0011638] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
147 Farrell DJ, Castanheira M, Sader HS, Jones RN. The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009). Journal of Infection 2010;61:476-83. [DOI: 10.1016/j.jinf.2010.08.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
148 Obolski U, Lourenço J, Thompson C, Thompson R, Gori A, Gupta S. Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae. Proc Natl Acad Sci U S A 2018;115:3102-7. [PMID: 29511100 DOI: 10.1073/pnas.1718712115] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
149 Varghese R, Neeravi A, Jacob JJ, Vasudevan K, Kumar JL, Subramanian N, Veeraraghavan B. Comparative genomics of invasive Streptococcus pneumoniae CC320/271 serotype 19F/19A before the introduction of pneumococcal vaccine in India. Mol Biol Rep 2021;48:3265-76. [PMID: 33876375 DOI: 10.1007/s11033-021-06353-6] [Reference Citation Analysis]
150 Ciruela P, Soldevila N, Selva L, Hernández S, Garcia-Garcia JJ, Moraga F, de Sevilla MF, Codina G, Planes AM, Esteva C, Coll F, Cardeñosa N, Jordan I, Batalla J, Salleras L, Muñoz-Almagro C, Domínguez A. Are risk factors associated with invasive pneumococcal disease according to different serotypes? Hum Vaccin Immunother 2013;9:712-9. [PMID: 23295982 DOI: 10.4161/hv.23270] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
151 McGhee P, Clark C, Kosowska-Shick KM, Nagai K, Dewasse B, Beachel L, Appelbaum PC. In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms. Antimicrob Agents Chemother 2010;54:230-8. [PMID: 19884376 DOI: 10.1128/AAC.01123-09] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
152 Mayanskiy N, Alyabieva N, Ponomarenko O, Pakhomov A, Kulichenko T, Ivanenko A, Lazareva M, Lazareva A, Katosova L, Namazova-Baranova L, Baranov A. Bacterial etiology of acute otitis media and characterization of pneumococcal serotypes and genotypes among children in Moscow, Russia. Pediatr Infect Dis J 2015;34:255-60. [PMID: 25232779 DOI: 10.1097/INF.0000000000000554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
153 Ríos Dueñas E, Rodríguez-Avial I, Picazo JJ. In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain. Eur J Clin Microbiol Infect Dis 2011;30:1621-5. [PMID: 21786208 DOI: 10.1007/s10096-011-1340-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
154 Zhao C, Li Z, Zhang F, Zhang X, Ji P, Zeng J, Hu B, Hu Z, Liao K, Sun H, Zhang R, Cao B, Zhuo C, Jia W, Mei Y, Chu Y, Xu X, Yang Q, Jin Y, Fu Q, Xu X, Li H, Wang L, Ni Y, Liang H, Wang H. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis 2017;17:804. [PMID: 29284419 DOI: 10.1186/s12879-017-2880-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
155 Zhao C, Zhang F, Chu Y, Liu Y, Cao B, Chen M, Yu Y, Liao K, Zhang L, Sun Z, Hu B, Lei J, Hu Z, Zhang X, Wang H. Phenotypic and genotypic characteristic of invasive pneumococcal isolates from both children and adult patients from a multicenter surveillance in China 2005-2011. PLoS One 2013;8:e82361. [PMID: 24349263 DOI: 10.1371/journal.pone.0082361] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
156 Kawaguchiya M, Urushibara N, Ghosh S, Kuwahara O, Morimoto S, Ito M, Kudo K, Kobayashi N. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period. Microb Drug Resist 2014;20:456-65. [PMID: 24766085 DOI: 10.1089/mdr.2013.0196] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
157 Chuang YP, Peng ZR, Tseng SF, Lin YC, Sytwu HK, Hsieh YC. Impact of the glpQ2 gene on virulence in a Streptococcus pneumoniae serotype 19A sequence type 320 strain. Infect Immun 2015;83:682-92. [PMID: 25422269 DOI: 10.1128/IAI.02357-14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
158 Cardoso NT, Santos BA, Barbosa AV, Superti SV, Teixeira LM, Neves FPG. Serotypes, antimicrobial resistance and genotypes of Streptococcus pneumoniae associated with infections in cancer patients in Brazil. Diagnostic Microbiology and Infectious Disease 2017;87:281-5. [DOI: 10.1016/j.diagmicrobio.2016.11.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
159 van der Linden M, Reinert RR, Kern WV, Imöhl M. Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children. BMC Infect Dis 2013;13:70. [PMID: 23384407 DOI: 10.1186/1471-2334-13-70] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
160 Soto K, Petit S, Hadler JL. Changing disparities in invasive pneumococcal disease by socioeconomic status and race/ ethnicity in Connecticut, 1998-2008. Public Health Rep 2011;126 Suppl 3:81-8. [PMID: 21836741 DOI: 10.1177/00333549111260S313] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
161 Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.). Emerg Infect Dis 2013;19:1074-83. [PMID: 23763847 DOI: 10.3201/eid1907.121830] [Cited by in Crossref: 158] [Cited by in F6Publishing: 148] [Article Influence: 19.8] [Reference Citation Analysis]
162 Delic S, Mijac V, Gajic I, Kekic D, Ranin L, Jegorovic B, Culic D, Cirkovic V, Siljic M, Stanojevic M, Paragi M, Markovic M, Opavski N. A Laboratory-Based Surveillance Study of Invasive Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae Diseases in a Serbian Pediatric Population-Implications for Vaccination. Diagnostics (Basel) 2021;11:1059. [PMID: 34207530 DOI: 10.3390/diagnostics11061059] [Reference Citation Analysis]
163 Aguiar SI, Brito MJ, Gonçalo-Marques J, Melo-Cristino J, Ramirez M. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 2010;28:5167-73. [PMID: 20558247 DOI: 10.1016/j.vaccine.2010.06.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
164 Dinleyici EC, Yargic ZA. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era. Expert Review of Vaccines 2014;7:1367-94. [DOI: 10.1586/14760584.7.9.1367] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
165 Muñoz-almagro C, Esteva C, Fernandez de Sevilla M, Selva L, Gene A, Pallares R. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. Journal of Infection 2009;59:75-82. [DOI: 10.1016/j.jinf.2009.05.012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
166 Williams DJ, Shah SS. Community-Acquired Pneumonia in the Conjugate Vaccine Era. J Pediatric Infect Dis Soc 2012;1:314-28. [PMID: 26619424 DOI: 10.1093/jpids/pis101] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
167 Silfverdal SA, Flodmark C, Rombo L, Tansey SP, Sidhu M, Trammel J, Emini EA, Gruber WC, Scott DA, Gurtman A. 13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): A phase 3, open-label trial. Vaccine 2013;31:1284-92. [DOI: 10.1016/j.vaccine.2012.12.066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
168 Metcalf BJ, Gertz RE Jr, Gladstone RA, Walker H, Sherwood LK, Jackson D, Li Z, Law C, Hawkins PA, Chochua S, Sheth M, Rayamajhi N, Bentley SD, Kim L, Whitney CG, McGee L, Beall B; Active Bacterial Core surveillance team. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clin Microbiol Infect 2016;22:60.e9-60.e29. [PMID: 26363404 DOI: 10.1016/j.cmi.2015.08.027] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 12.6] [Reference Citation Analysis]
169 Mcellistrem MC. Genetic diversity of the pneumococcal capsule: implications for molecular-based serotyping. Future Microbiology 2009;4:857-65. [DOI: 10.2217/fmb.09.58] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
170 Gil E, Noursadeghi M, Brown JS. The clinical and ecological impact of childhood pneumococcal vaccination. Br J Hosp Med (Lond) 2013;74:212-6. [PMID: 23571392 DOI: 10.12968/hmed.2013.74.4.212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
171 Mustapha MM, Harrison LH. Insights into seasonal dynamics of bacterial meningitis. Lancet Glob Health 2016;4:e345-6. [PMID: 27198826 DOI: 10.1016/S2214-109X(16)30078-X] [Reference Citation Analysis]
172 de la Campa AG, Ferrándiz MJ, Martín-Galiano AJ, García MT, Tirado-Vélez JM. The Transcriptome of Streptococcus pneumoniae Induced by Local and Global Changes in Supercoiling. Front Microbiol 2017;8:1447. [PMID: 28824578 DOI: 10.3389/fmicb.2017.01447] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
173 Critchley IA, Eckburg PB, Jandourek A, Biek D, Friedland HD, Thye DA. Review of ceftaroline fosamil microbiology: integrated FOCUS studies. Journal of Antimicrobial Chemotherapy 2011;66:iii45-51. [DOI: 10.1093/jac/dkr098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
174 de O Menezes AP, Campos LC, dos Santos MS, Azevedo J, Dos Santos RC, Carvalho Mda G, Beall BW, Martin SW, Salgado K, Reis MG, Ko AI, Reis JN. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007. Vaccine 2011;29:1139-44. [PMID: 21182994 DOI: 10.1016/j.vaccine.2010.12.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
175 Koutouzis EI, Daikos GL, Chatzichristou P, Michos AG, Koutouzi FI, Chrousos GP, Syriopoulou VP. Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986–2015. Vaccine 2018;36:5245-50. [DOI: 10.1016/j.vaccine.2018.07.055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
176 Olarte L, Kaplan SL, Barson WJ, Romero JR, Lin PL, Tan TQ, Hoffman JA, Bradley JS, Givner LB, Mason EO, Hultén KG. Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States. J Clin Microbiol 2017;55:724-34. [PMID: 27847379 DOI: 10.1128/JCM.01778-16] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 7.8] [Reference Citation Analysis]
177 Marra F, Vadlamudi NK. Efficacy and Safety of the Pneumococcal Conjugate-13 Valent Vaccine in Adults. Aging Dis 2019;10:404-18. [PMID: 31011485 DOI: 10.14336/AD.2018.0512] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
178 Tali-Maamar H, Laliam R, Bentchouala C, Touati D, Sababou K, Azrou S, Azzam M, Amhis W, Oussadou L, Belouni R, Smati F, Rahal K. Reprint of: Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010. Vaccine 2012;30 Suppl 6:G25-31. [PMID: 23153446 DOI: 10.1016/j.vaccine.2012.11.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
179 Domenech de Cellès M, Opatowski L, Salomon J, Varon E, Carbon C, Boëlle PY, Guillemot D. Intrinsic epidemicity of Streptococcus pneumoniae depends on strain serotype and antibiotic susceptibility pattern. Antimicrob Agents Chemother 2011;55:5255-61. [PMID: 21788454 DOI: 10.1128/AAC.00249-11] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
180 O'Brien TF, Stelling J. Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents. Clin Microbiol Rev 2011;24:281-95. [PMID: 21482726 DOI: 10.1128/CMR.00021-10] [Cited by in Crossref: 60] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
181 Brandileone MC, Almeida SC, Minamisava R, Andrade A. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil. Vaccine 2018;36:2559-66. [DOI: 10.1016/j.vaccine.2018.04.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
182 Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M, Benisty R, Givon-Lavi N, Hawkins PA, Cornick JE, Kwambana-Adams B, Law PY, Ho PL, Antonio M, Everett DB, Dagan R, von Gottberg A, Klugman KP, McGee L, Breiman RF, Bentley SD; Global Pneumococcal Sequencing Consortium. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis 2019;19:759-69. [PMID: 31196809 DOI: 10.1016/S1473-3099(19)30297-X] [Cited by in Crossref: 64] [Cited by in F6Publishing: 24] [Article Influence: 21.3] [Reference Citation Analysis]
183 Carvalho Mda G, Pimenta FC, Gertz RE Jr, Joshi HH, Trujillo AA, Keys LE, Findley J, Moura IS, Park IH, Hollingshead SK, Pilishvili T, Whitney CG, Nahm MH, Beall BW; Active Bacterial Core Surveillance Team. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol 2009;47:554-9. [PMID: 19116353 DOI: 10.1128/JCM.01919-08] [Cited by in Crossref: 91] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
184 Demczuk WHB, Martin I, Hoang L, Van Caeseele P, Lefebvre B, Horsman G, Haldane D, Gubbay J, Ratnam S, German G, Daley Bernier J, Strudwick L, McGeer A, Zhanel GG, Van Domselaar G, Graham M, Mulvey MR. Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing. PLoS One 2017;12:e0178040. [PMID: 28531208 DOI: 10.1371/journal.pone.0178040] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
185 Link-Gelles R, Taylor T, Moore MR; Active Bacterial Core Surveillance Team. Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020. Vaccine 2013;31:2572-7. [PMID: 23583813 DOI: 10.1016/j.vaccine.2013.03.049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
186 Tóthpál A, Laub K, Kardos S, Tirczka T, Kocsis A, VAN DER Linden M, Dobay O. Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination. Epidemiol Infect 2016;144:1563-73. [PMID: 26548594 DOI: 10.1017/S0950268815002757] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
187 Nahm MH, Lin J, Finkelstein JA, Pelton SI. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis 2009;199:320-5. [PMID: 19099489 DOI: 10.1086/596064] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 5.5] [Reference Citation Analysis]
188 Baek JY, Kang CI, Kim SH, Ko KS, Chung DR, Peck KR, Lee NY, Song JH. Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea. Diagn Microbiol Infect Dis 2018;91:287-90. [PMID: 29540263 DOI: 10.1016/j.diagmicrobio.2018.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
189 Domenech A, Tirado-Vélez JM, Fenoll A, Ardanuy C, Yuste J, Liñares J, de la Campa AG. Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006. Antimicrob Agents Chemother 2014;58:2393-9. [PMID: 24514095 DOI: 10.1128/AAC.02669-13] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
190 Tyrrell GJ. The changing epidemiology of Streptococcus pneumoniae serotype 19A clonal complexes. J Infect Dis 2011;203:1345-7. [PMID: 21398394 DOI: 10.1093/infdis/jir056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
191 Snape MD, Klinger CL, Daniels ED, John TM, Layton H, Rollinson L, Pestridge S, Dymond S, Galiza E, Tansey S, Scott DA, Baker SA, Jones TR, Yu L, Gruber WC, Emini EA, Faust SN, Finn A, Heath PT, Pollard AJ. Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age: A Double-blind Randomized Active-controlled Trial. Pediatric Infectious Disease Journal 2010;29:e80-90. [DOI: 10.1097/inf.0b013e3181faa6be] [Cited by in Crossref: 104] [Cited by in F6Publishing: 9] [Article Influence: 8.7] [Reference Citation Analysis]
192 Narwortey DK, Owusu-Ofori A, Slotved HC, Donkor ES, Ansah PO, Welaga P, Agongo G, Oduro AR. Nasopharyngeal carriage of Streptococcus pneumoniae among healthy children in Kassena-Nankana districts of Northern Ghana. BMC Infect Dis 2021;21:661. [PMID: 34233627 DOI: 10.1186/s12879-021-06302-5] [Reference Citation Analysis]
193 Žemličková H, Mališová L, Španělová P, Jakubů V, Kozáková J, Musílek M, Medvecký M. Molecular characterization of serogroup 19 Streptococcus pneumoniae in the Czech Republic in the post-vaccine era. J Med Microbiol 2018;67:1003-11. [PMID: 29856703 DOI: 10.1099/jmm.0.000765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
194 Ardanuy C, Marimón JM, Calatayud L, Giménez M, Alonso M, Grau I, Pallarés R, Pérez-Trallero E, Liñares J. Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies. PLoS One 2012;7:e43619. [PMID: 22928005 DOI: 10.1371/journal.pone.0043619] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
195 Grall N, Hurmic O, Nakib M, Longo M, Poyart C, Ploy M, Varon E, Raymond J; ORP Ile de France Ouest. Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine. Eur J Clin Microbiol Infect Dis 2011;30:1511-9. [DOI: 10.1007/s10096-011-1251-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
196 Hausdorff WP, Hoet B, Schuerman L. Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A? BMC Pediatr 2010;10:4. [PMID: 20122261 DOI: 10.1186/1471-2431-10-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 5.4] [Reference Citation Analysis]
197 Ben-Shimol S, Givon-Lavi N, Greenberg D, van der Beek BA, Leibovitz E, Dagan R. Substantial reduction of antibiotic-non-susceptible pneumococcal otitis media following PCV7/PCV13 sequential introduction. J Antimicrob Chemother 2020;75:3038-45. [PMID: 32946586 DOI: 10.1093/jac/dkaa263] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène J, Lommel P, Dieussaert I, Schuerman L. Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine. Pediatric Infectious Disease Journal 2009;28:S66-76. [DOI: 10.1097/inf.0b013e318199f8ef] [Cited by in Crossref: 199] [Cited by in F6Publishing: 67] [Article Influence: 15.3] [Reference Citation Analysis]
199 Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez M, Rolo D, Grau I, Martín R, Liñares J. Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007. CLIN INFECT DIS 2009;48:57-64. [DOI: 10.1086/594125] [Cited by in Crossref: 143] [Cited by in F6Publishing: 125] [Article Influence: 11.0] [Reference Citation Analysis]
200 Hanna JN, Humphreys JL, Murphy DM. Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005–2007. Medical Journal of Australia 2008;189:43-6. [DOI: 10.5694/j.1326-5377.2008.tb01897.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
201 Hu T, Weiss T, Owusu-Edusei K, Petigara T. Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States. J Med Econ 2020;23:1653-60. [PMID: 33084447 DOI: 10.1080/13696998.2020.1840216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
202 Rosen JB, Thomas AR, Lexau CA, Reingold A, Hadler JL, Harrison LH, Bennett NM, Schaffner W, Farley MM, Beall BW. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis. 2011;53:137-143. [PMID: 21690620 DOI: 10.1093/cid/cir326] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
203 Nelson GE, Gershman KA, Swerdlow DL, Beall BW, Moore MR. Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA. Emerg Infect Dis 2012;18:208-16. [PMID: 22306234 DOI: 10.3201/eid1802.110714] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
204 Jinno S, Jacobs MR. Pneumonia Due to Drug-Resistant Streptococcus pneumoniae. Curr Infect Dis Rep 2012;14:292-9. [DOI: 10.1007/s11908-012-0260-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
205 Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 2012;25:409-19. [PMID: 22763632 DOI: 10.1128/CMR.00018-12] [Cited by in Crossref: 107] [Cited by in F6Publishing: 47] [Article Influence: 10.7] [Reference Citation Analysis]
206 Ho P, Chiu SS, Ang I, Lau Y. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995–2009. Vaccine 2011;29:3270-5. [DOI: 10.1016/j.vaccine.2011.02.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
207 Jones RN, Jacobs MR, Sader HS. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. Int J Antimicrob Agents 2010;36:197-204. [PMID: 20558045 DOI: 10.1016/j.ijantimicag.2010.04.013] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
208 Schroeder MR, Stephens DS. Macrolide Resistance in Streptococcus pneumoniae. Front Cell Infect Microbiol 2016;6:98. [PMID: 27709102 DOI: 10.3389/fcimb.2016.00098] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 10.5] [Reference Citation Analysis]
209 Okade H, Funatsu T, Eto M, Furuya Y, Mizunaga S, Nomura N, Mitsuyama J, Yamagishi Y, Mikamo H. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period. J Infect Chemother 2014;20:423-8. [PMID: 24802765 DOI: 10.1016/j.jiac.2014.03.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
210 Hackel M, Lascols C, Bouchillon S, Hilton B, Morgenstern D, Purdy J. Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. Vaccine 2013;31:4881-7. [DOI: 10.1016/j.vaccine.2013.07.054] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 7.9] [Reference Citation Analysis]
211 Harrison LH, Shutt KA, Schmink SE, Marsh JW, Harcourt BH, Wang X, Whitney AM, Stephens DS, Cohn AA, Messonnier NE, Mayer LW. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. J Infect Dis 2010;201:1208-24. [PMID: 20199241 DOI: 10.1086/651505] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 6.3] [Reference Citation Analysis]
212 Jones RN, Farrell DJ, Mendes RE, Sader HS. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study. J Antimicrob Chemother 2011;66 Suppl 3:iii69-80. [PMID: 21482572 DOI: 10.1093/jac/dkr101] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
213 Harrison LH. Vaccines for prevention of group B meningococcal disease: Not your father's vaccines. Vaccine 2015;33 Suppl 4:D32-8. [PMID: 26116255 DOI: 10.1016/j.vaccine.2015.05.101] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
214 Meichtry J, Born R, Küffer M, Zwahlen M, Albrich WC, Brugger SD, Mühlemann K, Hilty M. Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study. Vaccine 2014;32:5185-91. [PMID: 25077419 DOI: 10.1016/j.vaccine.2014.07.060] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
215 von Gottberg A, Cohen C, de Gouveia L, Meiring S, Quan V, Whitelaw A, Crowther-Gibson P, Madhi SA, Whitney CG, Klugman KP. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine 2013;31:4200-8. [PMID: 23684826 DOI: 10.1016/j.vaccine.2013.04.077] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
216 Jefferies JMC, Tee WSN, Clarke SC. Molecular analysis of Streptococcus pneumoniae clones causing invasive disease in children in Singapore. J Med Microbiol 2011;60:750-5. [PMID: 21330410 DOI: 10.1099/jmm.0.030007-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
217 Song JH, Baek JY, Ko KS. Comparison of capsular genes of Streptococcus pneumoniae serotype 6A, 6B, 6C, and 6D isolates. J Clin Microbiol 2011;49:1758-64. [PMID: 21411593 DOI: 10.1128/JCM.02628-10] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
218 Chiba N, Morozumi M, Shouji M, Wajima T, Iwata S, Ubukata K; Invasive Pneumococcal Diseases Surveillance Study Group. Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010-2013. Emerg Infect Dis 2014;20:1132-9. [PMID: 24960150 DOI: 10.3201/eid2007.131485] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 11.1] [Reference Citation Analysis]
219 Mahjoub-Messai F, Doit C, Koeck JL, Billard T, Evrard B, Bidet P, Hubans C, Raymond J, Levy C, Cohen R, Bingen E. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal Vaccination for French children. J Clin Microbiol 2009;47:837-40. [PMID: 19109482 DOI: 10.1128/JCM.01547-08] [Cited by in Crossref: 48] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
220 Pitsiou GG, Kioumis IP. Pneumococcal vaccination in adults: Does it really work? Respiratory Medicine 2011;105:1776-83. [DOI: 10.1016/j.rmed.2011.07.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
221 Nisar MI, Shahid S, Jehan F, Ahmed S, Shakoor S, Kabir F, Hotwani A, Munir S, Khalid F, Muhammad S, Whitney CG, Ali A, Zaidi AKM, Omer SB, Iqbal N. Antimicrobial Resistance in Pneumococcal Carriage Isolates from Children under 2 Years of Age in Rural Pakistan. Microbiol Spectr 2021;:e0101921. [PMID: 34935431 DOI: 10.1128/Spectrum.01019-21] [Reference Citation Analysis]
222 Holland TL, Woods CW, Joyce M. Antibacterial susceptibility testing in the clinical laboratory. Infect Dis Clin North Am 2009;23:757-90, vii. [PMID: 19909884 DOI: 10.1016/j.idc.2009.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
223 Elberse KE, van de Pol I, Witteveen S, van der Heide HG, Schot CS, van Dijk A, van der Ende A, Schouls LM. Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing. PLoS One 2011;6:e20390. [PMID: 21637810 DOI: 10.1371/journal.pone.0020390] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
224 Park S, Parameswar AR, Demchenko AV, Nahm MH. Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups. Infect Immun 2009;77:3374-9. [PMID: 19451241 DOI: 10.1128/IAI.00319-09] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
225 Hu T, Done N, Petigara T, Mohanty S, Song Y, Liu Q, Lemus-wirtz E, Signorovitch J, Sarpong E, Weiss T. Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07275-9] [Reference Citation Analysis]
226 Ruiz García Y, Nieto Guevara J, Izurieta P, Vojtek I, Ortega-Barría E, Guzman-Holst A. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW. Expert Rev Vaccines 2021;20:45-57. [PMID: 33507135 DOI: 10.1080/14760584.2021.1873136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
227 Tomczyk S, Lynfield R, Schaffner W, Reingold A, Miller L, Petit S, Holtzman C, Zansky SM, Thomas A, Baumbach J, Harrison LH, Farley MM, Beall B, Mcgee L, Gierke R, Pondo T, Kim L. Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine. Clin Infect Dis 2016;62:1119-25. [DOI: 10.1093/cid/ciw067] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 10.3] [Reference Citation Analysis]
228 Rudolph K, Bulkow L, Bruce M, Zulz T, Reasonover A, Harker-Jones M, Hurlburt D, Hennessy T. Molecular resistance mechanisms of macrolide-resistant invasive Streptococcus pneumoniae isolates from Alaska, 1986 to 2010. Antimicrob Agents Chemother 2013;57:5415-22. [PMID: 23959308 DOI: 10.1128/AAC.00319-13] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
229 Poehling KA, Light LS, Rhodes M, Snively BM, Halasa NB, Mitchel E, Schaffner W, Craig AS, Griffin MR. Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease. Epidemiology 2010;21:340-6. [PMID: 20220521 DOI: 10.1097/EDE.0b013e3181d61af8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
230 Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. Evaluation of pneumococcal serotyping by multiplex PCR and quellung reactions. J Clin Microbiol 2013;51:4193-5. [PMID: 24025905 DOI: 10.1128/JCM.01876-13] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
231 Selva L, Ciruela P, Esteva C, Sevilla MF, Codina G, Hernandez S, Moraga F, García-garcía JJ, Planes A, Coll F, Jordan I, Cardeñosa N, Batalla J, Salleras L, Dominguez A, Muñoz-almagro C. Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis 2012;31:1487-95. [DOI: 10.1007/s10096-011-1468-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
232 Russell FM, Balloch A, Tang ML, Carapetis JR, Licciardi P, Nelson J, Jenney AW, Tikoduadua L, Waqatakirewa L, Pryor J. Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine. Vaccine. 2009;27:5685-5691. [PMID: 19616498 DOI: 10.1016/j.vaccine.2009.06.098] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
233 Vickers I, Fitzgerald M, Murchan S, Cotter S, O'Flanagan D, Cafferkey M, Humphreys H. Serotype distribution of Streptococcus pneumoniae causing invasive disease in the Republic of Ireland. Epidemiol Infect 2011;139:783-90. [PMID: 20642870 DOI: 10.1017/S0950268810001743] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
234 Klugman KP. Contribution of vaccines to our understanding of pneumococcal disease. Philos Trans R Soc Lond B Biol Sci 2011;366:2790-8. [PMID: 21893542 DOI: 10.1098/rstb.2011.0032] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
235 Wierzbowski AK, Karlowsky JA, Adam HJ, Nichol KA, Hoban DJ, Zhanel GG; on behalf of the Canadian Antimicrobial Resistance Alliance (CARA). Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008. Journal of Antimicrobial Chemotherapy 2013;69:59-66. [DOI: 10.1093/jac/dkt332] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
236 Rozenbaum MH, Boersma C, Postma MJ, Hak E. Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination. Expert Review of Vaccines 2014;10:187-99. [DOI: 10.1586/erv.10.163] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
237 Bikard D, Hatoum-Aslan A, Mucida D, Marraffini LA. CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 2012;12:177-86. [PMID: 22901538 DOI: 10.1016/j.chom.2012.06.003] [Cited by in Crossref: 216] [Cited by in F6Publishing: 175] [Article Influence: 24.0] [Reference Citation Analysis]
238 Chiang C, Chen Y, Jiang S, Liu D, Kao P, Teng H, Kuo T, Yao S, Tseng L, Wang Y, Wu H, Chang F, Lin T. National surveillance of invasive pneumococcal diseases in Taiwan, 2008–2012: Differential temporal emergence of serotype 19A. Vaccine 2014;32:3345-9. [DOI: 10.1016/j.vaccine.2014.04.061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
239 Rodgers GL, Arguedas A, Cohen R, Dagan R. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740]. Vaccine 2009;27:5429-30. [PMID: 19643215 DOI: 10.1016/j.vaccine.2009.07.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
240 Marimón JM, Alonso M, Rolo D, Ardanuy C, Liñares J, Pérez-Trallero E. Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009). Eur J Clin Microbiol Infect Dis 2012;31:1009-13. [PMID: 21901634 DOI: 10.1007/s10096-011-1399-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
241 Kim SH, Bae IK, Park D, Lee K, Kim NY, Song SA, Kim HR, Jeon GW, Urm SH, Shin JH. Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014. Biomed Res Int 2016;2016:6950482. [PMID: 27314035 DOI: 10.1155/2016/6950482] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
242 Proesmans MJ. Pneumococcal vaccination: time to move on? Eur J Pediatr 2010;169:1435-7. [PMID: 20473520 DOI: 10.1007/s00431-010-1215-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
243 Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--summary. Clin Microbiol Infect 2011;17 Suppl 6:1-24. [PMID: 21951384 DOI: 10.1111/j.1469-0691.2011.03602.x] [Cited by in Crossref: 186] [Cited by in F6Publishing: 139] [Article Influence: 18.6] [Reference Citation Analysis]
244 Malhotra A, Hunt RW, Doherty RR. Streptococcus pneumoniae sepsis in the newborn. J Paediatr Child Health 2012;48:E79-83. [PMID: 21199057 DOI: 10.1111/j.1440-1754.2010.01929.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
245 Campos LC, Carvalho Mda G, Beall BW, Cordeiro SM, Takahashi D, Reis MG, Ko AI, Reis JN. Prevalence of Streptococcus pneumoniae serotype 6C among invasive and carriage isolates in metropolitan Salvador, Brazil, from 1996 to 2007. Diagn Microbiol Infect Dis 2009;65:112-5. [PMID: 19709842 DOI: 10.1016/j.diagmicrobio.2009.06.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
246 Shouval DS, Greenberg D, Givon-lavi N, Porat N, Dagan R. Serotype Coverage of Invasive and Mucosal Pneumococcal Disease in Israeli Children Younger Than 3 Years by Various Pneumococcal Conjugate Vaccines. Pediatric Infectious Disease Journal 2009;28:277-82. [DOI: 10.1097/inf.0b013e31818e0e2e] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
247 Hon KL, Ip M, Chu WC, Wong W. Megapneumonia Coinfection: pneumococcus, Mycoplasma pneumoniae, and Metapneumovirus. Case Rep Med 2012;2012:310104. [PMID: 23193411 DOI: 10.1155/2012/310104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
248 Nunes MC, Madhi SA. Review on the immunogenicity and safety of PCV-13 in infants and toddlers. Expert Review of Vaccines 2014;10:951-80. [DOI: 10.1586/erv.11.76] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
249 de St Maurice A, Schaffner W, Griffin MR, Halasa N, Grijalva CG. Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era. J Infect Dis 2016;214:792-7. [PMID: 27247342 DOI: 10.1093/infdis/jiw222] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
250 Tasslimi A, Sison EJ, Story E, Alland D, Burday M, Morrison S, Nalmas S, Smith S, Thomas PA, Wenger P, Sinha A. Disappearance of vaccine-type invasive pneumococcal disease and emergence of serotype 19A in a minority population with a high prevalence of human immunodeficiency virus and low childhood immunization rates. Clin Vaccine Immunol 2009;16:1256-9. [PMID: 19515869 DOI: 10.1128/CVI.00140-09] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1030-1032. [PMID: 18845981 DOI: 10.1097/inf.0b013e31817e5188] [Cited by in Crossref: 61] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
252 Katz SE, Williams DJ. Pediatric Community-Acquired Pneumonia in the United States: Changing Epidemiology, Diagnostic and Therapeutic Challenges, and Areas for Future Research. Infect Dis Clin North Am 2018;32:47-63. [PMID: 29269189 DOI: 10.1016/j.idc.2017.11.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
253 Caierão J, Hawkins P, Sant'anna FH, da Cunha GR, d'Azevedo PA, McGee L, Dias C. Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern Brazil. PLoS One 2014;9:e111129. [PMID: 25356595 DOI: 10.1371/journal.pone.0111129] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
254 Adam D. Issues in pneumococcal disease and pneumococcal conjugate vaccines: highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9-13, 2009. Vaccine 2009;27:7133-7. [PMID: 19883868 DOI: 10.1016/j.vaccine.2009.08.084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
255 Lee LH, Gu XX, Nahm MH. Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention. Vaccines (Basel) 2014;2:112-28. [PMID: 26344470 DOI: 10.3390/vaccines2010112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
256 Song J, Dagan R, Klugman KP, Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012;30:2728-37. [DOI: 10.1016/j.vaccine.2012.01.091] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 9.8] [Reference Citation Analysis]
257 Baek JY, Park IH, So TM, Lalitha MK, Shimono N, Yasin RM, Carlos CC, Perera J, Thamlikitkul V, Hsueh PR, Van PH, Shibl AM, Song JH, Ko KS. Prevalence and characteristics of Streptococcus pneumoniae "putative serotype 6E" isolates from Asian countries. Diagn Microbiol Infect Dis 2014;80:334-7. [PMID: 25439447 DOI: 10.1016/j.diagmicrobio.2014.08.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
258 Harrison OB, Brueggemann AB, Caugant DA, van der Ende A, Frosch M, Gray S, Heuberger S, Krizova P, Olcen P, Slack M, Taha MK, Maiden MCJ. Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Microbiology (Reading) 2011;157:2181-95. [PMID: 21622526 DOI: 10.1099/mic.0.050518-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
259 Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee. Pediatr Infect Dis J 2013;32:604-9. [PMID: 23348816 DOI: 10.1097/INF.0b013e318287fe0d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
260 Patel SN, Pillai DR, Pong-Porter S, McGeer A, Green K, Low DE. In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008. J Antimicrob Chemother 2009;64:659-60. [PMID: 19578080 DOI: 10.1093/jac/dkp231] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
261 Crisinel PA, Chevalier I, Rallu F, Tapiero B, Lamarre V, Thibault R, Ovetchkine P. Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience. Eur J Pediatr 2010;169:1311-5. [DOI: 10.1007/s00431-010-1214-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
262 Picazo J, Ruiz-contreras J, Hernandez B, Sanz F, Gutierrez A, Cercenado E, Meseguer M, Delgado-iribarren A, Rodriguez-avial I, Méndez C. Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: A 2-year (2007–2009) laboratory-based surveillance in Madrid. Vaccine 2011;29:1770-6. [DOI: 10.1016/j.vaccine.2010.12.114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
263 Pandya GA, McEllistrem MC, Venepally P, Holmes MH, Jarrahi B, Sanka R, Liu J, Karamycheva SA, Bai Y, Fleischmann RD, Peterson SN. Monitoring the long-term molecular epidemiology of the pneumococcus and detection of potential 'vaccine escape' strains. PLoS One 2011;6:e15950. [PMID: 21264340 DOI: 10.1371/journal.pone.0015950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
264 Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 2009;64:507-10. [PMID: 19535383 DOI: 10.1093/jac/dkp210] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 5.7] [Reference Citation Analysis]
265 Song J, Baek JY, Cheong HS, Chung DR, Peck KR, Ko KS. Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007. Diagnostic Microbiology and Infectious Disease 2009;63:271-8. [DOI: 10.1016/j.diagmicrobio.2008.11.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
266 Sabharwal V, Figueira M, Pelton SI, Pettigrew MM. Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media. Microbes Infect 2012;14:712-8. [PMID: 22414497 DOI: 10.1016/j.micinf.2012.02.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
267 Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Sricharoenchai S, Chokephaibulkit K. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012. Hum Vaccin Immunother 2014;10:1866-73. [PMID: 25424794 DOI: 10.4161/hv.28675] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
268 Bowers JR, Driebe EM, Nibecker JL, Wojack BR, Sarovich DS, Wong AH, Brzoska PM, Hubert N, Knadler A, Watson LM, Wagner DM, Furtado MR, Saubolle M, Engelthaler DM, Keim PS. Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona. BMC Microbiol 2012;12:12. [PMID: 22251616 DOI: 10.1186/1471-2180-12-12] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
269 Ardanuy C, de la Campa AG, García E, Fenoll A, Calatayud L, Cercenado E, Pérez-Trallero E, Bouza E, Liñares J. Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain. Emerg Infect Dis 2014;20:1848-56. [PMID: 25340616 DOI: 10.3201/eid2011.131215] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
270 Conklin LM, Bigogo G, Jagero G, Hampton L, Junghae M, da Gloria Carvalho M, Pimenta F, Beall B, Taylor T, Plikaytis B, Laserson KF, Vulule J, Van Beneden C, Whitney CG, Breiman RF, Feikin DR. High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction. BMC Infect Dis 2016;16:18. [PMID: 26774803 DOI: 10.1186/s12879-015-1312-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
271 Pichon B, Bennett HV, Efstratiou A, Slack MPE, George RC. Genetic characteristics of pneumococcal disease in elderly patients before introducing the pneumococcal conjugate vaccine. Epidemiol Infect 2009;137:1049-56. [DOI: 10.1017/s0950268808001787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
272 Rückinger S, van der Linden M, Reinert RR, von Kries R. Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method. Vaccine 2010;28:5012-6. [PMID: 20546832 DOI: 10.1016/j.vaccine.2010.05.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
273 Critchley IA, Jacobs MR, Brown SD, Traczewski MM, Tillotson GS, Janjic N. Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem. Antimicrob Agents Chemother 2008;52:2639-43. [PMID: 18443117 DOI: 10.1128/AAC.00310-08] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
274 Moore MR, Link-gelles R, Schaffner W, Lynfield R, Holtzman C, Harrison LH, Zansky SM, Rosen JB, Reingold A, Scherzinger K, Thomas A, Guevara RE, Motala T, Eason J, Barnes M, Petit S, Farley MM, Mcgee L, Jorgensen JH, Whitney CG. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study. The Lancet Respiratory Medicine 2016;4:399-406. [DOI: 10.1016/s2213-2600(16)00052-7] [Cited by in Crossref: 102] [Cited by in F6Publishing: 43] [Article Influence: 17.0] [Reference Citation Analysis]
275 Lourenço J, Daon Y, Gori A, Obolski U. Pneumococcal Competition Modulates Antibiotic Resistance in the Pre-Vaccination Era: A Modelling Study. Vaccines (Basel) 2021;9:265. [PMID: 33809706 DOI: 10.3390/vaccines9030265] [Reference Citation Analysis]
276 McIntosh ED, Reinert RR. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev Vaccines 2011;10:109-29. [PMID: 21162625 DOI: 10.1586/erv.10.145] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
277 Moschioni M, De Angelis G, Melchiorre S, Masignani V, Leibovitz E, Barocchi M, Dagan R. Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel. Clinical Microbiology and Infection 2010;16:1501-4. [DOI: 10.1111/j.1469-0691.2010.03105.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
278 Zähner D, Gudlavalleti A, Stephens DS. Increase in pilus islet 2-encoded pili among Streptococcus pneumoniae isolates, Atlanta, Georgia, USA. Emerg Infect Dis 2010;16:955-62. [PMID: 20507746 DOI: 10.3201/eid1606.091820] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
279 Porat N, Benisty R, Trefler R, Givon-Lavi N, Dagan R. Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): marked differences between two ethnic populations in southern Israel. J Clin Microbiol 2012;50:3472-7. [PMID: 22875896 DOI: 10.1128/JCM.01309-12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
280 Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci 2013;28:4-15. [PMID: 23341706 DOI: 10.3346/jkms.2013.28.1.4] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
281 Domenech A, Ardanuy C, Tercero A, Garcia-somoza D, Santos S, Linares J. Dynamics of the pneumococcal population causing acute exacerbations in COPD patients in a Barcelona hospital (2009-12): comparison with 2001-04 and 2005-08 periods. Journal of Antimicrobial Chemotherapy 2014;69:932-9. [DOI: 10.1093/jac/dkt476] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
282 McCollum ED, Nambiar B, Deula R, Zadutsa B, Bondo A, King C, Beard J, Liyaya H, Mankhambo L, Lazzerini M, Makwenda C, Masache G, Bar-Zeev N, Kazembe PN, Mwansambo C, Lufesi N, Costello A, Armstrong B, Colbourn T. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study. PLoS One 2017;12:e0168209. [PMID: 28052071 DOI: 10.1371/journal.pone.0168209] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
283 Richter S, Heilmann K, Dohrn C, Riahi F, Beekmann S, Doern G. Changing Epidemiology of Antimicrobial‐Resistant Streptococcus pneumoniae in the United States, 2004–2005. CLIN INFECT DIS 2009;48:e23-33. [DOI: 10.1086/595857] [Cited by in Crossref: 108] [Cited by in F6Publishing: 101] [Article Influence: 8.3] [Reference Citation Analysis]
284 McLaughlin JM, Utt EA, Hill NM, Welch VL, Power E, Sylvester GC. A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States. Hum Vaccin Immunother 2016;12:206-12. [PMID: 26376039 DOI: 10.1080/21645515.2015.1069452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
285 Leach AJ, Morris PS, McCallum GB, Wilson CA, Stubbs L, Beissbarth J, Jacups S, Hare K, Smith-Vaughan HC. Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001. BMC Infect Dis 2009;9:121. [PMID: 19650933 DOI: 10.1186/1471-2334-9-121] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
286 Schroeder MR, Chancey ST, Thomas S, Kuo WH, Satola SW, Farley MM, Stephens DS. A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance Mechanisms. Clin Infect Dis 2017;65:990-8. [PMID: 28903506 DOI: 10.1093/cid/cix446] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
287 Song JH. Advances in pneumococcal antibiotic resistance. Expert Rev Respir Med 2013;7:491-8. [PMID: 24138693 DOI: 10.1586/17476348.2013.816572] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
288 Klugman KP, Dagan R, Malley R, Whitney CG. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 773-815.e18. [DOI: 10.1016/b978-0-323-35761-6.00045-6] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
289 Dinleyici EC, Yargic ZA. Pneumococcal conjugated vaccine: PHiD-CV. Expert Review of Anti-infective Therapy 2014;7:1063-74. [DOI: 10.1586/eri.09.84] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
290 Siira L, Jalava J, Tissari P, Vaara M, Kaijalainen T, Virolainen A. Clonality behind the increase of multidrug-resistance among non-invasive pneumococci in Southern Finland. Eur J Clin Microbiol Infect Dis 2012;31:867-71. [DOI: 10.1007/s10096-011-1386-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
291 Temime L, Boelle PY, Opatowski L, Guillemot D. Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population. PLoS One 2008;3:e3244. [PMID: 18802466 DOI: 10.1371/journal.pone.0003244] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
292 Janapatla RP, Hsu MH, Du JF, Hsieh YC, Lin TY, Chiu CH. Sequence types and antimicrobial susceptibility of invasive streptococcus pneumoniae isolates from a region with high antibiotic selective pressure and suboptimal vaccine coverage. Pediatr Infect Dis J 2010;29:467-9. [PMID: 20027125 DOI: 10.1097/INF.0b013e3181cb45f3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
293 Tarragó D, Aguilar L, García R, Gimenez MJ, Granizo JJ, Fenoll A. Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008. Antimicrob Agents Chemother 2011;55:2297-302. [PMID: 21343456 DOI: 10.1128/AAC.01494-10] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
294 Desmet S, Theeten H, Laenen L, Cuypers L, Maes P, Bossuyt W, Van Heirstraeten L, Peetermans WE, Lagrou K. Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium. Emerg Infect Dis 2022;28:1606-14. [PMID: 35876488 DOI: 10.3201/eid2808.212440] [Reference Citation Analysis]
295 Almeida SCG, Lo SW, Hawkins PA, Gladstone RA, Cassiolato AP, Klugman KP, Breiman RF, Bentley SD, McGee L, Brandileone MC. Genomic surveillance of invasive Streptococcus pneumoniae isolates in the period pre-PCV10 and post-PCV10 introduction in Brazil. Microb Genom 2021;7. [PMID: 34609274 DOI: 10.1099/mgen.0.000635] [Reference Citation Analysis]
296 Jacobs MR. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther 2008;6:619-35. [PMID: 18847402 DOI: 10.1586/14787210.6.5.619] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
297 De Serres G, Pilishvili T, Link-Gelles R, Reingold A, Gershman K, Petit S, Farley MM, Harrison LH, Lynfield R, Bennett NM. Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period. Vaccine. 2012;30:4067-4072. [PMID: 22525797 DOI: 10.1016/j.vaccine.2012.04.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
298 Andam CP, Hanage WP. Mechanisms of genome evolution of Streptococcus. Infect Genet Evol 2015;33:334-42. [PMID: 25461843 DOI: 10.1016/j.meegid.2014.11.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
299 Gagetti P, Faccone D, Reijtman V, Fossati S, Rodriguez M, Veliz O, Ceriana P, Regueira M, Corso A. Characterization of Streptococcus pneumoniae invasive serotype 19A isolates from Argentina (1993–2014). Vaccine 2017;35:4548-53. [DOI: 10.1016/j.vaccine.2017.07.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
300 Jourdain S, Smeesters P, Denis O, Dramaix M, Sputael V, Malaviolle X, Van Melderen L, Vergison A. Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins. Clinical Microbiology and Infection 2011;17:907-14. [DOI: 10.1111/j.1469-0691.2010.03410.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
301 Cohn AC, Harrison LH. Meningococcal vaccines: current issues and future strategies. Drugs 2013;73:1147-55. [PMID: 23839656 DOI: 10.1007/s40265-013-0079-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
302 Dinleyici EC, Yargic ZA. Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine. Expert Review of Vaccines 2014;8:977-86. [DOI: 10.1586/erv.09.68] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
303 Aaberge IS. Experience with pneumococcal conjugate vaccine in Norway. Expert Review of Vaccines 2014;8:159-65. [DOI: 10.1586/14760584.8.2.159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
304 Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA, Miller E, George R. Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales. J Clin Microbiol 2013;51:820-7. [PMID: 23269742 DOI: 10.1128/JCM.01917-12] [Cited by in Crossref: 53] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
305 Desai AP, Sharma D, Crispell EK, Baughman W, Thomas S, Tunali A, Sherwood L, Zmitrovich A, Jerris R, Satola SW, Beall B, Moore MR, Jain S, Farley MM. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia. Pediatr Infect Dis J 2015;34:1168-74. [PMID: 26226445 DOI: 10.1097/INF.0000000000000849] [Cited by in Crossref: 79] [Cited by in F6Publishing: 50] [Article Influence: 13.2] [Reference Citation Analysis]
306 Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason EO. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010;48:520-5. [PMID: 20018815 DOI: 10.1128/JCM.01200-09] [Cited by in Crossref: 73] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
307 Ho P, Chiu SS, Chan MY, Ang I, Chow K, Lau Y. Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong. Diagnostic Microbiology and Infectious Disease 2011;71:327-34. [DOI: 10.1016/j.diagmicrobio.2011.09.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
308 Obaro S. Seven-valent pneumococcal conjugate vaccines for developing countries. Expert Rev Vaccines 2009;8:1051-61. [PMID: 19627187 DOI: 10.1586/erv.09.66] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
309 Vestrheim DF, Høiby EA, Aaberge IS, Caugant DA. Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin Vaccine Immunol 2010;17:325-34. [PMID: 20107006 DOI: 10.1128/CVI.00435-09] [Cited by in Crossref: 88] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
310 Hawkins P, Mercado E, Chochua S, Castillo ME, Reyes I, Chaparro E, Gladstone R, Bentley SD, Breiman RF, Metcalf BJ, Beall B, Ochoa TJ, McGee L. Key features of invasive pneumococcal isolates recovered in Lima, Peru determined through whole genome sequencing. Int J Med Microbiol 2017;307:415-21. [PMID: 28756964 DOI: 10.1016/j.ijmm.2017.07.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
311 Polkowska A, Rinta-Kokko H, Toropainen M, Palmu AA, Nuorti JP. Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland. Vaccine 2021;39:3216-24. [PMID: 33934915 DOI: 10.1016/j.vaccine.2021.02.030] [Reference Citation Analysis]
312 Strachan RE, Cornelius A, Gilbert GL, Gulliver T, Martin A, McDonald T, Nixon GM, Roseby R, Ranganathan S, Selvadurai H, Smith G, Soto-Martinez M, Suresh S, Teoh L, Thapa K, Wainwright CE, Jaffe A; Australian Research Network in Empyema. Bacterial causes of empyema in children, Australia, 2007-2009. Emerg Infect Dis 2011;17:1839-45. [PMID: 22000353 DOI: 10.3201/eid1710.101825] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
313 Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011;29:3398-412. [DOI: 10.1016/j.vaccine.2011.02.088] [Cited by in Crossref: 178] [Cited by in F6Publishing: 170] [Article Influence: 16.2] [Reference Citation Analysis]
314 Golden AR, Baxter MR, Davidson RJ, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Hoban DJ, Zhanel GG, Adam HJ; Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD. Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16. J Antimicrob Chemother 2019;74:iv39-47. [PMID: 31505644 DOI: 10.1093/jac/dkz286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
315 Gounder PP, Bruden D, Rudolph K, Zulz T, Hurlburt D, Thompson G, Bruce MG, Hennessy TW. Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged ≥5 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008-2013. Vaccine 2018;36:691-7. [PMID: 29279284 DOI: 10.1016/j.vaccine.2017.12.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
316 Mills N, Best EJ, Murdoch D, Souter M, Neeff M, Anderson T, Salkeld L, Ahmad Z, Mahadevan M, Barber C, Brown C, Walker C, Walls T. What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination. J Paediatr Child Health 2015;51:300-6. [PMID: 25175818 DOI: 10.1111/jpc.12710] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
317 Silva SM, Rodrigues ICG, Santos RDS, Ternes YMF. The direct and indirect effects of the pneumococcal conjugated vaccine on carriage rates in children aged younger than 5 years in Latin America and the Caribbean: a systematic review. Einstein (Sao Paulo) 2020;18:eRW4890. [PMID: 31778464 DOI: 10.31744/einstein_journal/2020RW4890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
318 Ho PL, Chiu SS, Law PY, Chan EL, Lai EL, Chow KH. Increase in the nasopharyngeal carriage of non-vaccine serogroup 15 Streptococcus pneumoniae after introduction of children pneumococcal conjugate vaccination in Hong Kong. Diagn Microbiol Infect Dis 2015;81:145-8. [PMID: 25483278 DOI: 10.1016/j.diagmicrobio.2014.11.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
319 Sundaresh B, Xu S, Noonan B, Mansour MK, Leong JM, van Opijnen T. Host-informed therapies for the treatment of pneumococcal pneumonia. Trends Mol Med 2021:S1471-4914(21)00189-1. [PMID: 34376327 DOI: 10.1016/j.molmed.2021.07.008] [Reference Citation Analysis]
320 Pimenta FC, Carvalho MDGS, Gertz RE, Bastos-Rocha CGB, Oliveira LSC, Lacerda Pigosso L, Lima JA, Marquez Franco C, Andrade AL, Beall BW. Serotype and genotype distributions of pneumococcal carriage isolates recovered from Brazilian children attending day-care centres. J Med Microbiol 2011;60:1455-9. [PMID: 21636673 DOI: 10.1099/jmm.0.031450-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
321 Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO. The changing epidemiology of invasive pneumococcal disease at a tertiary children’s hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012;31:228-234. [PMID: 22330164 DOI: 10.1097/inf.0b013e31823dcc72] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
322 Hsieh YC, Wang C, Lai S, Lai J, Wong K, Huang Y, Chang K, Chiu C, Lin T. Necrotizing Pneumococcal Pneumonia With Bronchopleural Fistula Among Children in Taiwan. Pediatric Infectious Disease Journal 2011;30:740-4. [DOI: 10.1097/inf.0b013e31821b10c3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
323 Croucher NJ, Finkelstein JA, Pelton SI, Mitchell PK, Lee GM, Parkhill J, Bentley SD, Hanage WP, Lipsitch M. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet 2013;45:656-63. [PMID: 23644493 DOI: 10.1038/ng.2625] [Cited by in Crossref: 264] [Cited by in F6Publishing: 218] [Article Influence: 29.3] [Reference Citation Analysis]
324 Qian J, Yao K, Xue L, Xie G, Zheng Y, Wang C, Shang Y, Wang H, Wan L, Liu L, Li C, Ji W, Wang Y, Xu P, Yu S, Tang Y, Yang Y. Diversity of pneumococcal surface protein A (PspA) and relation to sequence typing in Streptococcus pneumoniae causing invasive disease in Chinese children. Eur J Clin Microbiol Infect Dis 2012;31:217-23. [DOI: 10.1007/s10096-011-1296-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
325 Brandileone MDC, Zanella RC, Almeida SC, Cassiolato AP, Lemos APSD, Salgado MM, Higa FT, Minamisava R, Andrade AL. Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil. Vaccine 2019;37:5357-63. [DOI: 10.1016/j.vaccine.2019.07.043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
326 Cassiolato AP, Almeida SCG, Andrade AL, Minamisava R, Brandileone MCC. Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil. PLoS One 2018;13:e0208211. [PMID: 30496296 DOI: 10.1371/journal.pone.0208211] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
327 Vestrheim DF, Steinbakk M, Aaberge IS, Caugant DA. Postvaccination increase in serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex. Clin Vaccine Immunol 2012;19:443-5. [PMID: 22237889 DOI: 10.1128/CVI.05563-11] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
328 Harboe ZB, Dalby T, Weinberger DM, Benfield T, Mølbak K, Slotved HC, Suppli CH, Konradsen HB, Valentiner-Branth P. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis. 2014;59:1066-1073. [PMID: 25034421 DOI: 10.1093/cid/ciu524] [Cited by in Crossref: 207] [Cited by in F6Publishing: 192] [Article Influence: 25.9] [Reference Citation Analysis]
329 Ricketson LJ, Wood ML, Vanderkooi OG, MacDonald JC, Martin IE, Demczuk WH, Kellner JD; Calgary Streptococcus pneumoniae Epidemiology Research (CASPER) investigators. Trends in asymptomatic nasopharyngeal colonization with streptococcus pneumoniae after introduction of the 13-valent pneumococcal conjugate vaccine in Calgary, Canada. Pediatr Infect Dis J 2014;33:724-30. [PMID: 24463806 DOI: 10.1097/INF.0000000000000267] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 4.9] [Reference Citation Analysis]
330 Van Effelterre T, Moore MR, Fierens F, Whitney CG, White L, Pelton SI, Hausdorff WP. A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccination. Vaccine 2010;28:3650-60. [DOI: 10.1016/j.vaccine.2010.03.030] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
331 Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013;32:203-207. [PMID: 23558320 DOI: 10.1097/inf.0b013e318275614b] [Cited by in Crossref: 218] [Cited by in F6Publishing: 73] [Article Influence: 24.2] [Reference Citation Analysis]
332 Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, Fritzell B, Varon E. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010;28:6114-21. [DOI: 10.1016/j.vaccine.2009.05.037] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
333 Hanna JN, Humphreys JL, Murphy DM, Smith HV. Invasive pneumococcal disease in non‐Indigenous people in north Queensland, 2001–2009. Medical Journal of Australia 2010;193:392-6. [DOI: 10.5694/j.1326-5377.2010.tb03965.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
334 Mayanskiy N, Savinova T, Alyabieva N, Ponomarenko O, Brzhozovskaya E, Lazareva A, Katosova L, Kozlov R. Antimicrobial resistance, penicillin-binding protein sequences, and pilus islet carriage in relation to clonal evolution of Streptococcus pneumoniae serotype 19A in Russia, 2002-2013. Epidemiol Infect 2017;145:1708-19. [PMID: 28318472 DOI: 10.1017/S0950268817000541] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
335 Balsells E, Dagan R, Yildirim I, Gounder PP, Steens A, Muñoz-Almagro C, Mameli C, Kandasamy R, Givon Lavi N, Daprai L, van der Ende A, Trzciński K, Nzenze SA, Meiring S, Foster D, Bulkow LR, Rudolph K, Valero-Rello A, Ducker S, Vestrheim DF, von Gottberg A, Pelton SI, Zuccotti G, Pollard AJ, Sanders EAM, Campbell H, Madhi SA, Nair H, Kyaw MH. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect 2018;77:368-78. [PMID: 29964140 DOI: 10.1016/j.jinf.2018.06.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 12.3] [Reference Citation Analysis]
336 Best EJ, Walls T, Souter M, Neeff M, Anderson T, Salkeld L, Ahmad Z, Mahadevan M, Walker C, Murdoch D, Mills N. Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine. Vaccine 2016;34:3840-7. [DOI: 10.1016/j.vaccine.2016.05.041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
337 Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, Byington CL. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics 2013;132:e17-24. [PMID: 23733800 DOI: 10.1542/peds.2012-3900] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
338 Agarwal HS, Latifi SQ. Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine. Pathogens 2021;10:727. [PMID: 34207609 DOI: 10.3390/pathogens10060727] [Reference Citation Analysis]
339 Fenoll A, Aguilar L, Giménez M, Vicioso M, Robledo O, Granizo J, Coronel P. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000–May 2001) and 10 years after (May 2010–May 2011) introduction of conjugate vaccines for child immunisation in Spain. International Journal of Antimicrobial Agents 2012;40:18-23. [DOI: 10.1016/j.ijantimicag.2012.03.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
340 Ciccotelli WA, Poutanen SM, Alqahtani M, Morris SK, Cox P, Low DE, Pillai DR, Opavsky MA. A new twist on an old problem. A case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19 A. Pediatr Infect Dis J 2009;28:74-5. [PMID: 19057453 DOI: 10.1097/INF.0b013e31818bfeb4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
341 Elberse KE, van der Heide HG, Witteveen S, van de Pol I, Schot CS, van der Ende A, Berbers GA, Schouls LM. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine. Vaccine 2012;30:7644-51. [PMID: 22521844 DOI: 10.1016/j.vaccine.2012.04.021] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
342 Brueggemann AB, Muroki BM, Kulohoma BW, Karani A, Wanjiru E, Morpeth S, Kamau T, Sharif S, Scott JA. Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine. PLoS One 2013;8:e81539. [PMID: 24282605 DOI: 10.1371/journal.pone.0081539] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
343 Balsalobre L, Ferrándiz MJ, de Alba G, de la Campa AG. Nonoptimal DNA topoisomerases allow maintenance of supercoiling levels and improve fitness of Streptococcus pneumoniae. Antimicrob Agents Chemother 2011;55:1097-105. [PMID: 21173181 DOI: 10.1128/AAC.00783-10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
344 Richter SS, Musher DM. The Ongoing Genetic Adaptation of Streptococcus pneumoniae. J Clin Microbiol 2017;55:681-5. [PMID: 27974545 DOI: 10.1128/JCM.02283-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
345 Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarragó D. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47:1012-1020. [PMID: 19225097 DOI: 10.1128/jcm.01454-08] [Cited by in Crossref: 179] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
346 Ceyhan M, Ozsurekci Y, Gürler N, Ozkan S, Sensoy G, Belet N, Hacimustafaoglu M, Celebi S, Keser M, Dinleyici EC, Alhan E, Baki A, Oner AF, Uzun H, Kurugol Z, Aycan AE, Gurbuz V, Karadag Oncel E, Celik M, Ozkaya Parlakay A. Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey. Clin Vaccine Immunol 2013;20:972-6. [PMID: 23637041 DOI: 10.1128/CVI.00765-12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
347 Aguiar SI, Pinto FR, Nunes S, Serrano I, Melo-Cristino J, Sá-Leão R, Ramirez M, de Lencastre H. Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J Clin Microbiol 2010;48:101-8. [PMID: 19864476 DOI: 10.1128/JCM.00665-09] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
348 Korona-Glowniak I, Maj M, Siwiec R, Niedzielski A, Malm A. Molecular Epidemiology of Streptococcus pneumoniae Isolates from Children with Recurrent Upper Respiratory Tract Infections. PLoS One 2016;11:e0158909. [PMID: 27415833 DOI: 10.1371/journal.pone.0158909] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
349 Tan TQ. Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA. Expert Review of Anti-infective Therapy 2014;8:117-25. [DOI: 10.1586/eri.09.132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
350 Micoli F, Bagnoli F, Rappuoli R, Serruto D. The role of vaccines in combatting antimicrobial resistance. Nat Rev Microbiol 2021;19:287-302. [PMID: 33542518 DOI: 10.1038/s41579-020-00506-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
351 Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B, Shelly MA, Mahon BE, Nahm MH; Active Bacterial Core Surveillance Team. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 2008;198:1818-22. [PMID: 18983249 DOI: 10.1086/593339] [Cited by in Crossref: 121] [Cited by in F6Publishing: 112] [Article Influence: 9.3] [Reference Citation Analysis]
352 Spanelova P, Jakubu V, Malisova L, Musilek M, Kozakova J, Papagiannitsis CC, Bitar I, Hrabak J, Pantosti A, Del Grosso M, Zemlickova H. Whole genome sequencing of macrolide resistant Streptococcus pneumoniae serotype 19A sequence type 416. BMC Microbiol 2020;20:224. [PMID: 32711478 DOI: 10.1186/s12866-020-01909-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
353 Choudhury SA, Ladson G, Kabir MS. Evaluation of serotype-specific immunity to Streptococcus pneumoniae in pregnant women and cord blood of infants: impact of race and ethnicity. J Natl Med Assoc 2012;104:251-7. [PMID: 22973674 DOI: 10.1016/s0027-9684(15)30160-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
354 Shorr AF, Kollef M, Eckburg PB, Llorens L, Friedland HD. Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials. Diagn Microbiol Infect Dis 2013;75:298-303. [PMID: 23357290 DOI: 10.1016/j.diagmicrobio.2012.12.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
355 Pletz MW, Welte T, Ott SR. Advances in the prevention, management, and treatment of community-acquired pneumonia. F1000 Med Rep 2010;2:53. [PMID: 21173853 DOI: 10.3410/M2-53] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
356 Ricketson LJ, Vanderkooi OG, Wood ML, Leal J, Kellner JD. Clinical features and outcomes of serotype 19A invasive pneumococcal disease in Calgary, Alberta. Can J Infect Dis Med Microbiol 2014;25:e71-5. [PMID: 24855484 DOI: 10.1155/2014/196748] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
357 Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Andersen PH, Howitz M, Krogfelt KA, Lambertsen L, Konradsen HB. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine. 2010;28:2642-2647. [PMID: 20096392 DOI: 10.1016/j.vaccine.2010.01.017] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 5.3] [Reference Citation Analysis]
358 Simonsen L, Taylor RJ, Schuck-paim C, Lustig R, Haber M, Klugman KP. Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis. The Lancet Respiratory Medicine 2014;2:387-94. [DOI: 10.1016/s2213-2600(14)70032-3] [Cited by in Crossref: 138] [Cited by in F6Publishing: 64] [Article Influence: 17.3] [Reference Citation Analysis]
359 Che D, Zhou H, He J, Wu B. Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination. BMC Health Serv Res 2014;14:56. [PMID: 24507480 DOI: 10.1186/1472-6963-14-56] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
360 Pilishvili T, Whitney CG. Use of data to drive pneumococcal conjugate vaccine policy. Lancet Infect Dis 2018;18:366-8. [PMID: 29396002 DOI: 10.1016/S1473-3099(18)30054-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
361 Ljutic B, Ochs M, Messham B, Ming M, Dookie A, Harper K, Ausar SF. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants. Vaccine 2012;30:2981-8. [PMID: 22381074 DOI: 10.1016/j.vaccine.2012.02.038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
362 Ferrándiz MJ, de la Campa AG. The fluoroquinolone levofloxacin triggers the transcriptional activation of iron transport genes that contribute to cell death in Streptococcus pneumoniae. Antimicrob Agents Chemother 2014;58:247-57. [PMID: 24145547 DOI: 10.1128/AAC.01706-13] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
363 Shetty AK, Maldonado YA. Current Trends in Streptococcus pneumoniae Infections and Their Treatment. Curr Pediatr Rep 2013;1:158-69. [DOI: 10.1007/s40124-013-0021-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
364 Kim SH, Chung DR, Song JH, Baek JY, Thamlikitkul V, Wang H, Carlos C, Ahmad N, Arushothy R, Tan SH, Lye D, Kang CI, Ko KS, Peck KR; Asian Network for Surveillance of Resistant Pathogens (ANSORP). Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes. Vaccine 2020;38:6065-73. [PMID: 31590932 DOI: 10.1016/j.vaccine.2019.09.065] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
365 Thomas JC, Figueira M, Fennie KP, Laufer AS, Kong Y, Pichichero ME, Pelton SI, Pettigrew MM. Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence. PLoS One 2011;6:e18649. [PMID: 21533186 DOI: 10.1371/journal.pone.0018649] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
366 Savinova T, Brzhozovskaya E, Alyabieva N, Lazareva A, Shagin D, Mayanskiy N. Multiple-Drug Resistant Nasopharyngeal Streptococcus pneumoniae Isolated in Russia: Serotypes, Antimicrobial Susceptibility, and Molecular Characterization of the Emergent Serotype 13/ST2754 Lineage. Microb Drug Resist 2021. [PMID: 34357824 DOI: 10.1089/mdr.2021.0074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
367 Shin J, Baek JY, Kim SH, Song JH, Ko KS. Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries. J Antimicrob Chemother 2011;66:1001-4. [PMID: 21393143 DOI: 10.1093/jac/dkr048] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
368 Thompson WW, Moore MR, Weintraub E, Cheng PY, Jin X, Bridges CB, Bresee JS, Shay DK. Estimating influenza-associated deaths in the United States. Am J Public Health 2009;99 Suppl 2:S225-30. [PMID: 19797736 DOI: 10.2105/AJPH.2008.151944] [Cited by in Crossref: 94] [Cited by in F6Publishing: 59] [Article Influence: 7.2] [Reference Citation Analysis]
369 Rudolph K, Bruce MG, Bulkow L, Zulz T, Reasonover A, Harker-Jones M, Hurlburt D, Hennessy TW. Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986-2010. Int J Circumpolar Health 2013;72. [PMID: 23984273 DOI: 10.3402/ijch.v72i0.20854] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
370 Ramos V, Parra EL, Duarte C, Moreno J. Characterization of Streptococcus pneumoniae invasive serotype 19A isolates recovered in Colombia. Vaccine 2014;32:755-8. [PMID: 24374499 DOI: 10.1016/j.vaccine.2013.12.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
371 Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008;47:1388-95. [PMID: 18959493 DOI: 10.1086/592972] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 7.8] [Reference Citation Analysis]
372 de St Maurice A, Grijalva CG, Fonnesbeck C, Schaffner W, Halasa NB. Racial and Regional Differences in Rates of Invasive Pneumococcal Disease. Pediatrics 2015;136:e1186-94. [PMID: 26459652 DOI: 10.1542/peds.2015-1773] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
373 Hsieh YC, Lin TL, Chang KY, Huang YC, Chen CJ, Lin TY, Wang JT. Expansion and evolution of Streptococcus pneumoniae serotype 19A ST320 clone as compared to its ancestral clone, Taiwan19F-14 (ST236). J Infect Dis 2013;208:203-10. [PMID: 23559465 DOI: 10.1093/infdis/jit145] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
374 Urbancikova I, Prymula R, Goldblatt D, Roalfe L, Prymulova K, Kosina P. Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia. Vaccine 2017;35:5186-93. [PMID: 28797727 DOI: 10.1016/j.vaccine.2017.07.103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
375 Mrkvan T, Pelton SI, Ruiz-Guiñazú J, Palmu AA, Borys D. Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience. Expert Rev Vaccines 2018;17:797-818. [PMID: 30185083 DOI: 10.1080/14760584.2018.1516551] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
376 Henriques-normark B, Blomberg C, Dagerhamn J, Bättig P, Normark S. The rise and fall of bacterial clones: Streptococcus pneumoniae. Nat Rev Microbiol 2008;6:827-37. [DOI: 10.1038/nrmicro2011] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 5.2] [Reference Citation Analysis]
377 Sakata H, Kuroki H, Ouchi K, Tajima T, Iwata S; World's First Oral Carbapenem Study Group. Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxil. J Infect Chemother 2017;23:307-11. [PMID: 28238680 DOI: 10.1016/j.jiac.2017.01.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
378 Gertz RE Jr, Li Z, Pimenta FC, Jackson D, Juni BA, Lynfield R, Jorgensen JH, Carvalho Mda G, Beall BW; Active Bacterial Core Surveillance Team. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 2010;201:770-5. [PMID: 20178139 DOI: 10.1086/650496] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 7.3] [Reference Citation Analysis]